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Abstract
Malaria is a deadly tropical disease caused by protozoa of the genus plasmodium. The
malaria parasite life cycle involves three cycles namely the sporogony (mosquito stages),
exo-erythrocytic schizogony (human liver stages), and the erythrocytic schizogony (human
blood stage). We consider a mathematical model for malaria involving, susceptible red
blood cells, latent infected red blood cells, active infected red blood cells, intracellular
parasites, extracellular parasites and eector cells. We extend the model to include all the
three stages of the malaria life cycle. The eect of treatment on the prognosis of malaria is
also introduced in these models. The models are analysed mathematically and numerically.
One of the question addressed in our study is: what replicative characteristics oer the
parasite opportunities to evade the host immune system? The results showed that the
longer it takes to produce the parasites, the higher the chance that an infected red blood
cell will be identied and apoptosised by the eector cells. Our sensitivity analysis results
show that poor parametric estimation has serious implications on the prognosis of the
disease. Treatment results suggest that a high drug ecacy can stop the development of
the disease. The study has revealed that the parasite replicative characteristics enable the
parasite to evade the immune response during the red blood stage malaria. Firstly, we have
found that the parasite has a strategy of infecting older red blood cells as a strategy to
evade immune surveillance. Secondly, we discovered that the administration of an eective
drug can prevent malaria in all stages despite the current belief that only a malaria vaccine
can reliably protect against all stages malaria infection. We recommend treatment to be
used in areas where anti-malarial drugs do not show resistance to the parasites. We also
recommend that individuals with malaria or showing some symptoms should be treated
for both malaria and chronic infections.
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Opsomming
Malaria is 'n dodelike tropiese siekte wat veroorsaak word deur die protoso ë van die genus
Plasmodium. Die malariaparasiet lewensiklus bestaan uit drie siklusse naamlik die sporo-
gony (muskiet stadiums), exo-erythrocytic schizogony (menslike lewer stadiums), en die
erythrocytic schizogony (menslike bloed stadium). Ons kyk na 'n wiskundige model vir
malaria, vatbaar rooibloedselle, latente besmet rooi bloedselle, aktief besmette rooibloed-
selle, intrasellul êre parasiete, ekstrasellulêre parasiete en eektor selle. Ons brei die model
om al die drie fases van die lewensiklus malaria te sluit. Die eek van behandeling op
die voorspelling van malaria is ook in hierdie modelle ingevoer. Die modelle is wiskundig
en numeries ontleed. Een van die vraag in ons studie is: watter replicative eienskappe
bied die parasiet geleenthede om die gasheer se immuunrespons te ontduik? Die resultate
het getoon dat hoe langer dit neem om die parasiete te produseer, hoe groter die kans
dat besmette rooibloedselle sal geïdentiseer word en deur die eektor selle apoptosised.
Ons sensitiwiteitsanalise resultate toon dat die arme parametriese beraming het ernstige
implikasies vir die voorspelling van die siekte. Behandeling resultate dui daarop dat 'n hoë
dwelm doeltreendheid kan die ontwikkeling van die siekte stop. Die studie het getoon dat
die parasiet replicative eienskappe die parasiet in staat stel om die immuunreaksie tydens
die rooi bloed stadium malaria te ontduik. Eerstens, het ons gevind dat die parasiet het 'n
strategie van besmet om ouer rooi bloed selle as' n strategie om immuun toesig te ontduik.
Tweedens, het ons ontdek dat die administrasie van 'n doeltreende middel kan malaria
in alle stadiums voorkom ten spyte van die huidige oortuiging dat slegs' n malaria-entstof
betroubaar kan beskerm teen alle stadia malaria infeksie. Ons raai dat behandeling gebruik
word in gebiede waar die anti-malaria medisyne nie weerstand toon aan die parasiete. Ons
beveel ook aan dat individue met malaria of wat sekere simptome het, behandel moet word
vir beide malaria en chroniese malaria infeksies.
ii
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Glossary
Abbreviation Meaning
RBCs Red Blood Cells
LVCs Liver Cells
MGCs Midgut Cells
CD in CD4 Cluster of Dierentiation 4
CD in CD8 Cluster of Dierentiation 8
HIV Human immunodeciency virus
AIDS Acquired Immunodeciency Syndrome
ODE Ordinary Dierential Equation
T in T-cell Thymus
ACT Artemisin-based Combination Therapy
WHO World Health Organization
DDT Dichloro-Diphenyl-Trichloroethane
UNICEF United Nations Children's Fund
SIV Simian Immunodeciency Virus
CDC Centers for Disease Control & Prevention
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Chapter 1
Introduction
1.1 Background
Malaria is a mosquito borne infectious disease caused by protozoan of genus plasmod-
ium [73]. The four species that can infect humans are; Plasmodium falciparum, which
causes severe disease and possibly death [41, 92] if not diagnosed and treated promptly,
the other three plasmodium vivax, plasmodium ovale and plasmodium malariae gener-
ally cause milder disease that is rarely fatal. [50]. The parasite was discovered in 1880 by
Charles Laveran [45], who was working in the military hospital in Constantine, Algeria. He
observed the parasites in a blood smear taken from a patient who had just died of malaria.
But Laveran linked the cause of malaria with the monkeys [8]. In 1902 Sir Ronald Ross dis-
covered the malaria parasite in the gastrointestinal tract of the anopheles mosquito. This
led to the realization that malaria was transmitted by the Anopheles mosquito [98]. This
study [98] laid the foundation for combating the disease such as the use of the pesticide
Dichloro-Diphenyl -Trichloroethane (DDT) for the control of mosquitoes during world war
II [63] and the treatment drug chloroquine in 1950.
1
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FIG. 1.1. A diagram showing malaria endemic area in Africa.
Malaria remains a burden in terms of morbidity and mortality for developing countries
(FIG. 1.1) with tropical and subtropical climates. Malaria is prevalent in these regions
because of heavy rainfall, warm consistent temperatures and high humidity conditions that
are conducive to the development of the larvae. Temperature determines vector survival,
incubation period and transmission while heavy rainfall causes the stagnant waters in which
their larvae mature and provide mosquito with the environment needed for continuous
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breeding [23, 77].
It is estimated that half of the world's population, over 3.3 billion lives in malaria endemic
areas. There are about 300 to 500 million cases of clinical malaria reported [24, 67, 80, 96],
resulting in 1.5 to 2.7 million deaths annually. sub-Sahara Africa is the region with the
highest infection rate [96]. In this region alone, the disease kills at least one million people
each year and is responsible for as many as half of the deaths in African children under
the age of 5 [96], and accounts for 20% of all childhood deaths globally. Malaria decreases
the gross domestic product by as much as 1.3% in countries with high disease rate [70, 96].
This contributes to poverty and underdevelopment in most sub-Sahara countries.
The Malaria parasites are introduced into the human blood stream after a bite by a female
anopheles mosquito. Parasites in the form of sporozoites, enter the liver where they divide
several times before maturing into schizonts which rupture and release merozoites which
completing the initial parasite replication in the liver (exo-erythrocytic schizogony). Dur-
ing this initial stage, two species, namely, plasmodium vivax and plasmodium ovale can
remain dormant (hypnozoites) in the liver and cause replace by invading the blood stream
weeks, or even years later. After this initial replication in the liver, the merozoites enter
the blood stage where they undergo asexual multiplication in the erythrocytes (erythro-
cytic schizogony). Mature merozoites in the blood stream are capable of invading the red
blood cell. At this point the symptoms of disease will start to manifest, in the form of
fever, headache, vomiting, chills, weakness and sweating. These symptoms are intermittent
depending on the immunity of the host. Some merozoites dierentiate and develop into
sexual forms of the parasite, called male and female gametocytes, that circulate in the
bloodstream [2, 11, 41, 45, 101].
When a mosquito bites an infected human, it ingests the gametocytes which initiate par-
asite multiplication replication in the mosquito known as the sporogonic cycle. In the
mosquito's stomach, male and female gametes fuse to form diploid zygotes which develop
into ookinetes that invade the mosquito midgut wall and form oocysts. The oocysts grow,
rupture, and release thousands of sporozoites. Sporozoites invade the mosquito salivary
glands from where they can be injected into human hosts to continue the infection process
when the mosquito takes a blood meal [45, 50]. Malaria can be prevented [41, 46, 92]
mainly through awareness of risk; People at risk include those who have no or those with
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low immunity to malaria like young children, pregnant woman and visitors that travel to
tropical areas from malaria free areas. Malaria can be prevented by preventing bites from
infected mosquitoes. This can be achieved by wearing long clothes that cover as much of the
skin as possible, treating exposed parts of the body with insect repellent, using insecticide-
impregnated bed nets while sleeping and spraying indoors with insecticide around sleeping
areas. People visiting malaria endemic areas are advised to take anti-malarial drugs be-
fore entering these area. It is advisable for all residents of malaria endemic areas to be
diagnosed for malaria routinely and be treated if they test positive.
Despite the intense research and number of clinical trial, currently there is no eective
vaccine [23, 64] and there has been very little success in producing such vaccines [64].
Accurate diagnosis of malaria is an integral part of treatment of malaria patients and pre-
vention of further spread of malaria in the community. Treating malaria depends on many
factors including disease severity, the species of malaria parasite causing the infection and
the part of the world in which the infection was acquired. The use of a simple, inexpen-
sive and rapid diagnosis tests for malaria may be of increasing importance as countries
in Africa shift from low-cost anti-malarial to more expensive drugs Artemisin-based Com-
bination Therapy (ACT). ACT is the most eective strategy for plasmodium falciparum
infection recommended by WHO in the face of wide spread drug resistance [63, 96].
Parasites have become resistance due to usual anti-malarial drug like chloroquine which
was the drug of choice to treat malaria for decades following World War II; it was stopped
after parasites became resistant to it. Also the mosquito has became resistant to most
insecticide [6, 54], DDT which was a very eective vector control pesticide was stopped
because the mosquito became resistant to it [63]. Malaria can be managed with proper
diagnosis and prompt treatment. Early diagnosis and prompt treatment are the principle
technical components of the global strategy to control malaria and is highly dependent
on the ecacy, safety, availability, aordability and acceptability of anti-malarial drugs
[91]. An eective anti-malarial drug not only reduces mortality and morbidity of malaria
but also reduces the risk of drug resistance. Due to drug resistance of parasites towards,
available anti-malarial drugs for various regions are given below;
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TABLE. 1.1. The table that shows the drug resistance for anti-malarial drug
Anti-malarial drug Places that shows drug resistance
Chloroquine Plasmodium falciparum species all areas
of the world except the following:
North Africa; the Middle East
(though cases have been reported
in Oman, Yemenand Iran);Haiti; Dominican
Republic; rural areas of Mexico;
and Central America,north and west
of the Panama canal [86].
Fansidar South East Asia;the Indian
sub-continent; the Amazon basin;
many countries in Africa south
of the Sahara; and Oceania [90].
Meoquine South East Asia especially in Thailand;
parts of Africa and South America;
the Middle East; and Oceania [90].
Quinine South East Asia;parts of Africa;
Brazil; and Oceania [90].
Halofantrine Thailand and shows cross resistance
with meoquine, fansidar and
sulfadoxine-pyrimethamine [90].
1.2 Statement of the problem
In-host mathematical models are important and necessary to enhance our understanding
of the dynamics of the Malaria parasites [58]. Such models can also be used to give an
insight into the eectiveness of treatment drug and other intervention strategies. In this
study, we investigate the dynamics of the malaria parasite during the red blood cycle, then
extend the model to look at all the stages of the malaria life cycle, namely; liver stage, red
blood cell stage and mosquito stage. These models, which also include the eector cells
will be used to address the following questions:
(i) What replicative characteristics oer the parasite opportunities to evade the host
immune system?
(ii) Can we nd the critical eector cell killing rates which must be maintained (or ex-
ceeded) to ensure that the parasite does not establish itself within the host?
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(iii) What are the eect of therapy on the prognosis of the malaria disease?
(iv) What are these models' contribution to the public health?
1.3 Objectives of the study
Malaria remains one of the world's worst problem. It is shown that more people are
clinically ill with malaria than any other disease [96]. According to WHO estimates, in
2008 alone, there occurred 190− 311 million clinical cases of malaria [11, 96]. Hopes that
malaria might be eradicated have proved impossible to realize. In many tropical areas,
the threat of epidemic malaria is increasing and the control measures are becoming less
eective. For this malaria associated burden to be reduced, we conduct a study whose
objectives are summarized as follows;
 To understand biological processes that enable the parasites to evade the immune
response.
 To gaining insights into the dynamics between the malaria parasites and the immune
system
 To investigate the eect of anti-malarial therapy on the prognosis of the disease.
 To contribution policy recommendations on management of malaria.
1.4 Organization of the work
This work is organized as follows: Chapter 2 reviews various studies about malaria. Chap-
ter 3 provides mathematical and numerical tools necessary for this study. Chapter 4
presents the model with the following classes; susceptible RBCs, latent RBCs, active in-
fected RBCs, intracellular parasites, extracellular parasites and eector cells. Also presents
the eects of treatment. The model is analysed mathematically and numerically, and the
results are discussed. Chapter 5 presents the treatment model with three stages of the
malaria life cycle, namely; (i) the liver stage which comprises of; susceptible liver cells
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(LVCs), infected liver cells (LVCs), sporozoites and schizonts inside the liver cells (LVCs),
(ii) the blood stage which consist of; susceptible red blood cells (RBCs), infected RBCs,
merozoites, trophozoites, and schizonts inside the red blood cells (RBCs), (iii) the mosquito
stage which has; susceptible midgut cells (MGCs), infected midgut cells (MGCs), gameto-
cytes. The model also has an eector cell class. The mathematical and numerical simula-
tions are done, the results are also discussed. Chapter 6 concludes what has been discussed
in the results and suggests limitations, recommendations, and possibilities of future work.
This is followed by the appendix.
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Literature review
It is over one hundred years since malaria was recognized as a disease in humans. Initially,
malaria was known as mal
′
aria implying that the disease was caused by bad or spoiled
air. The fever clinical symptoms were related to swaps and low lying water. In 1880, Lav-
eran discovered parasites inside red blood cells of a sick person and mistakenly related the
disease to monkeys following his earlier study which identied the same parasites inside a
monkey's red blood cells [8].
The study by Ross (see [8] and the references therein) on malaria has become the basis of
epidemiological studies of malaria including vector spread, treatment etc. and these have
led to immunological studies of the disease [8, 41]. To demonstrate the seriousness of the
malaria epidermic, we have analysed available records for the trend. Records regarding
malaria clinical cases and mortality before the year 1950 are not available. The treatment
drug chloroquine was discovered in 1950 and at almost the same time the pesticide DDT
was discovered. From available records depicted by FIG. 2.1, it is evident that malaria
clinical cases were in decline between 1950 and 1975 due to eective vector control pro-
grams and the eectiveness of the treatment drug chloroquine [66, 76]. Over a long period
of administration of chloroquine, the parasites developed resistance to the drug [6, 54] and
currently, chloroquine is not recommended for treatment of malaria in sub-Sahara Africa
[66]. The trend for malaria clinical cases has been on the increase since 1975 (FIG. 2.1).
There appears to be a link between malaria and HIV/AIDS (FIG. 2.1). During the late
1980's, HIV/AIDS became an epidemic in most sub-Sahara Africa. Coincidentally, when
8
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FIG. 2.1. A diagram showing amplied relationship between HIV and malaria
HIV/AIDS exploded malaria clinical cases also started to increase rapidly.
We want to exercise caution about the link mentioned above and to note that the rapid
increase in malaria clinical cases during the late 1980's could also be related to other fac-
tors such as the collapse of the vector control programs following the deterioration in most
economies in sub-Sahara Africa, but it may also be due to weakened immune responses in
patients co-infected with HIV and malaria.
There are four species of plasmodium that are known to infect humans namely, Plasmodium
falciparum, Plasmodium malariae, Plasmodium vivax, and Plasmodium ovale. The dis-
tribution of the various malaria parasites are indicated in the [TABLE 2.1]. Plasmodium
falciparum, which causes more deaths in humans, is found mainly in tropical and sub-
tropical areas of the world which include sub-Sahara Africa and most of the poor regions
of Asia. These parasites develop through a cycle depicted in (FIG.2.2) and discussed in de-
tail in [26, 50]. Clearly from this gure, the malaria life cycle is very complex and involves
stages within the mosquito and the human host. If malaria is to be controlled and/or
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TABLE. 2.1. The table shows plasmodium species and characteristics.
Species Global distribution Recur Type of RBCs Infection
P. falciparum Tropical and sub-
tropical worldwide Recrudescence All Severe anaemia
P. malariae Worldwide Recrudescence Older RBCs Milder disease
P. ovale Africa Relapse Young RBCs Normal infection
P. vivax Asia, Latin America
some part of Africa Relapse Young RBCs Normal infection
FIG. 2.2. Malaria life cycles, copied from Parasite image library [10]
.
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eradicated, it is important to understand the factors that inuence malaria pathogenesis
[1, 31]. It is evident from (FIG.2.2) that the important questions for the mathematical
study of malaria are both epidemiological and immunological and span several levels of
biological organization.
Knowing the factors involved in pathogenesis, however, is only the rst step towards quan-
tifying how each factor inuences the result [51]. As a sequel to the study by Anderson
et al. [1], several studies Hetzel and Anderson [31], Antia et al. [2], etc., have studied
the within-host cellular dynamics of blood stage malaria. Hetzel and Anderson [31] inves-
tigated the properties of a mathematical model of blood stage infection of malaria. The
analysis [31], done in the absence of the host immune response to demonstrate the rela-
tionship between host and parasites parameters, led to the determination of parameters
necessary for the successful invasion and persistence of the parasites. The parameters in
Hetzel and Anderson [31] are used in this study as a rst approximation in our model to
understand the role of treatment and innate immune response to malaria pathogenesis.
A more recent study by Antia et al. [2] has considered acute malaria infections with a
view to determine the dynamics of parasite and anaemia during acute primary malaria in-
fections and why some strains of malaria reach higher densities and cause greater anaemia
than others. While most studies agree that specic immunity does not play a major role in
the initial dynamics of pathogenesis, there is considerable controversy over which factors
drive the dynamics shortly after infection [1, 30, 31, 55].
Despite these numerous studies on malaria pathogenesis, the relative signicance of dif-
ferent factors inuencing malaria pathogenesis cited in [1, 2, 31], the development of the
disease is far from clear [60]. So far, many studies focus on the innate immune response
[31, 34] to understand the RBC-parasites interaction and a few on adaptive immune re-
sponse. However the fact that researchers have successfully categorized the immune re-
sponses does not imply understanding of these processes. For example, Stevenson and Riley
[82] have discussed how several adaptive immune response components like macrophages
and natural killer cells are involved in the innate immune response and concluded that the
interaction of those cells remains speculative and conicting experimental data has opened
a way for mathematical models of pathogenesis to be used as tools to achieve deeper un-
derstanding of this process [31].
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Several studies on the innate immune response to malaria infection have been formulated
[13, 65, 84, 89]. A study by Su et. al [84] on the synchronization of parasite replication in
dierent red blood cells, considers an age-structural human malaria infection of red blood
cells. The numerical simulation results in this study show that synchronization with regu-
lar periodic oscillation occurs when the replication rates increase. A more recent study by
Niger and Gumel [65] has investigated the innate immune response to malaria infection and
the eect of imperfect vaccines. The simulation results [65] show that a vaccine ecacy of
at least 87% is necessary to eliminate Infected Red Blood Cells (IRBCs )in vivo.
The study by McQueen and McKenzie [55] considers the susceptibility of red blood cells
and the dynamics of malaria infection. The authors [55] assume a predator-prey type re-
lationship between a population of replicating parasites and a replenishing population of
red blood cells. The study explores the hypothesis that some malaria-parasite species that
infect humans such as Plasmodium malariae and Plasmodium vivax have preference for
particular age classes of red blood cells. Our study considers the infection of red blood cells
by Plasmodium falciparum which has dierent infection characteristics [34, 55]. We want
to investigate whether Plasmodium falciparum too has a tendency for age selection like
the other malaria species, noting that the dierence in infection characteristics between
Plasmodium falciparum and the species considered by McQueen and McKenzie [55] occurs
primarily in the range of parameters used [34].
A review by Engwerda and Good [23] considered the interaction between malaria parasites
and the host immune system and revealed the potential for designing and implementing
new vaccine and drug programs through understanding of cell-immune, cell-parasite inter-
action. This study [23] included the adaptive response which is not part of this study but
provides insight into the cell-parasite dynamics which has guided our study.
A review by Mideo et al. [58] recommended the use of mathematical models as a tool for
rening knowledge of within-host processes and has suggested why under certain circum-
stances mathematical models may be better than experimentation. Generally, however,
Mideo et al. [58] recommends the use of both approaches since together these approaches
possess the potential for informing the design of intervention and health policy for address-
ing lingering questions about the basic biology of malaria which should guide the model
formulation. The malaria parasite replication is a very complex process and involves three
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stages as shown in (FIG. 2.2). This complicated replication cycle has implications regard-
ing eradication of malaria which is too expensive and probably unrealistic for poor resource
sub-Sahara African countries. A treatment or vaccination strategy suggested by mathe-
matical models may contribute to cutting cost of intervention programs.
This study will attempt to quantitatively predict the pattern of pathogenesis as a function
some underlying within-host regulatory facts. However, as the biology of malaria pathogen-
esis is very complex and involves many factors, this study will include only those biological
process that we believe can plausibly explain the dynamic of malaria pathogenesis.
McKenzie and Bossert [34, 53, 55] modelled malaria pathogenesis using a system of cou-
pled dierential equations involving only uninfected RBCs, infected RBCs and merozoites.
These studies omitted the detailed biology such as how the merozoites are replicated asex-
ually and concentrated on the basic infection dynamics that lead to clinical malaria. The
aim in those studies was to understand pathogenesis and not how the immune system
responds to infection. However, the study by Hoshen et al. [34] gives useful insights and
conclusions that have guided our study. The question one ask is whether a simplied model
such as Hoshen et al. [34] can yield reliable information to guide planning and policy. Fur-
thermore, one wonders whether these simple models can reliably estimate the severity of
the disease?
Some larger models [61] have included more biological process such as innate and adaptive
immune responses. However, such studies have lacked clinically determined parameter val-
ues to calibrate and validate their models. The objective behind such large models is to
determine parasite replication mechanisms but in the absence of biologically determined
laws it has proved dicult to justify results from such models. It is known that when
merozoites infect red blood cells, to initiate the asexual replication of the merozoite pop-
ulation [55, 61], not all infected red blood cells contribute to the population of merozoites
since some of them are apoptosed by the natural killer cells. Adjustment to reect this fact
has been done in an ad hoc manner [40]. The dierences in accounting for the replication
laws for malaria, TB and HIV [25, 55] are indicative of the absence of clear biological
understanding of the processes. Some authors have assumed very simple laws [34, 55] to
keep the models parsimonious. The lack of biological facts on this subject has aected our
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denition of the parasite replication law which we admit has no biological basis.
These complex mathematical models on malaria pathogenesis have considered the develop-
ment of cerebral malaria in children and adult travelers living in non endemic malaria areas
and have concluded that severe malaria is an immune-mediated disease [4]. This study [4]
considered the role of innate and adaptive immune responses in terms of (i) protection
from clinical malaria and (ii) their potential role in immunopathology and the subsequence
development of clinical immunity. Another study [3] has determined the potential con-
tribution of innate immune responses to the early pro-inammatory cytokine response to
Plasmodium falciparum malaria. The study examined the kinetics and cellular sources of
interferon-gamma production in response to infection of red blood cells. The study con-
cludes that early interferon-gamma response could reduce red blood cells infection.
There is considerable controversy over which factors drive the malaria pathogenesis shortly
after infection [1, 30, 31, 55]. Some of the assumptions made to explain the dierences
in the initial dynamics of malaria strains include virulence evolution [2, 14, 27, 49], (ii)
red blood cell age specic infection strategy [55] and (iii) innate or early specic immune
responses to regulate the initial dynamics of infection and anaemia [21, 29]. Antia et al.
[2], however, have given two reasons why it is dicult to ascertain the contribution of these
factors to the dynamics of acute infection namely (i) limited data on the dynamics of the
parasite and loss of RBCs following infection of humans with human malaria parasites and
(ii) the dynamics of the infection could involve many interacting populations.
Several studies have investigated the potential for a vaccine as the best strategy to combat
malaria targeting the liver stage for a vaccine [23, 33, 59]. According to [23], this stage
poses many obstacles to anti-infection vaccines and drugs. These include: (i) the liver
stage malaria parasites have distinct metabolism which helps them to evade anti-malarial
drugs (ii) Plasmodium malaria parasites can lie dormant in the liver and relapse to blood
infection after months or even years. According to Morrow and Moss [63], liver stage para-
sites cannot be targeted by any licensed drug except primaquine which is fatal to pregnant
women and diabetic individuals.
Our hypothesis in this study follows from the observation made by McQueen and McKenzie
[55]. We ask the question whether Plasmodium falciparum targets older red blood cells as
a strategy for accelerating parasite replication. Although we have not developed an age-
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structured model, we have manipulated the natural death term in the infected red blood
cell population to achieve our goal. It is suggested in [39, 104] that CD8 cells may not
function optimally in individuals suering from chronic illnesses, we have investigate this
scenario and accordingly have made a recommendation regarding the treatment of malaria
for individuals suering from chronic infections.
Despite a large area in research on malaria pathogenesis (within-host mechanisms through
which plasmodium parasite causes disease) [5, 23, 55, 58] many questions remain unan-
swered. Issues in pathogenesis need to be explored to develop better treatment [58, 60]. It
is known that most of the drugs act best against replicating pathogens in combination with
eective immunological responses [5]. There is a need also to better understand eector
cell mechanism in the development of immunity to malaria [1].
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Mathematical tools
3.1 The denition and computation of R0
Denition 3.1.1 The basic reproduction number (R0), sometimes called the basic repro-
ductive rate or the basic reproductive ratio of an infection is the average number of sec-
ondary cases caused by an infected individual introduced in a completely susceptible popu-
lation [20].
For the case of a single infected compartment, R0 is simply the product of the infection
rate and the mean duration of the infection [93]. But for models with several infected
compartments, this denition is not sucient. That is a more sophisticated technique is
required as reviewed below. In this thesis, we only give a brief overview of the calculation
of the basic reproduction number R0, using the next generation method discussed by
Diekmann [20] and van den Driessche et. al [93]. Let x = (x1, . . . , xn)
t
with xi ≥ 0, be
the number of individuals in each compartment (i = 1, . . . , n). We sort the compartments
so that the rst m compartments correspond to infected individuals and then, dene the
parasite free equilibria as x0 = {x ≥ 0 | xi = 0, i = 1, . . . , m}.
For the computation of R0, it is important to distinguish new infections from all other
changes in the population. As illustrated in gure (3.1), we let: Fi (x) be the rate of
appearance of new infections in compartment i, V+i be the rate of transfer of individuals
into compartment i and V−i (x) be the rate of transfer of individuals out of compartment
i.
16
Stellenbosch University http://scholar.sun.ac.za
Chapter 3. A mathematical tools 17
PSfrag replacements
Fi (x)
V+i (x)
V−i (x)
FIG. 3.1. Representation of F and V
Fi (x) ,V
+
i (x) , and V
−
i (x) are dierentiable continuous functions. In general, we can
express a system of dierential equations of the form x˙ = fi (x) in the form that accounts
for inow and outow (3.1) as:
x˙ (t) = Fi (x)− Vi (x) , andVi(x) = V
−
i (x)− V
+
i (x), for i = 1, ..., n.
Let the functions Fi (x) ,V
+
i (x) , and V
−
i (x) satisfy the following conditions.
(A1) : If x ≥ 0, then Fi,V
+
i ,V
−
i ≥ 0.
(A2) : If xi = 0, then V
−
i = 0. In particular, if x ∈ x0, then V
−
i = 0, for i = 1, ...., m.
(A3) : If i > m,Fi = 0.
(A4) : If x ∈ x0, then Fi (x) = 0, and V
+
i (x) = 0.
(A5) : If f (x) = 0 , then the eigenvalues of Df (x0) have negative real parts and x0 is the
parasite free equilibrium.
The conditions listed above allow us to partition the matrix DF(x) as shown in Remark
1.
Remark 1 DF (x0) is the derivative
[
∂fi
∂xj
]
evaluated at DFE. The conditions (A1 − A5)
allow us to partition the matrix DF(x0) and DV(x0) as;
DF(x0) =
(
F 0
0 0
)
and DV(x0) =
(
V 0
J3 J4
)
,
where F and V are m×m matrices dened as F =
[
∂F〉
∂xj
(x0)
]
, and V =
[
∂V〉
∂xj
(x0)
]
. Since
F is non-negative, V is a non-singular matrix and all eigenvalues of J4 have positive real
parts.
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If f(x) satises (A1−A5), then the reproductive ratio is dened as R0 = η
(
FV−1
)
, where
η is the spectral radius [93].
When R0 < 1, the infection dies out, except for a model which exhibits a backward
bifurcation. For R0 > 1, the infection spreads in a population. Thus R0 is a threshold
parameter such that when R0 < 1, the population remains healthy because the disease
fails to establish itself. The stability of the disease free equilibrium point (maintaining the
conditions for absence of disease in a population) is discussed by Diekmann ([20]), and van
den Driessche [93]. The stability of parasite free equilibrium point is stated in theorem
3.1.2.
Theorem 3.1.2 The parasite free equilibrium point is locally asymptotically stable for
R0 < 1 and unstable for R0 > 1.
The proof of this theorem is given in several studies [16, 43, 44].
3.2 The Routh-Hurwitz criterion
Let
anS
n + an−1S
n−1 + · · ·+ a1S
0 + a0 = 0, (3.1)
be a characteristic equation of a given Jacobian matrix. The Routh-Hurwitz table [36, 62]
for the characteristic equation (3.1) of degree n can be determined as illustrated in TABLE
3.1.
TABLE. 3.1. The Routh-Hurwitz table showing the characteristic equation
Sn an an−2 an−4 an−6
Sn−1 an−1 an−3 an−5 an−7
Sn−2 b1 =
an−1an−2 − anan−3
an−1
b2 =
an−1an−4 − anan−5
an−1
b3 =
an−1an−6 − anan−7
an−1
Sn−3
b1an−3 − b2an−1
b1
b1an−5 − b3an−1
b1
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
S0
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This table can be used as follows:
 If there are sign changes in the rst column, then the eigenvalues have positive real
parts.
 The number of sign changes in the rst column is equal to the number of positive
real roots of the characteristic equation.
 If there exists a mixture of positive and negative signs, then the given system is
unstable.
 If there are no sign changes in the rst column, then all eigenvalues are either positive
or negative. If there are negative signs only, then the eigenvalues have negative real
parts and the system is stable.
3.3 Sensitivity analysis
The parameter values and assumptions of any model are subject to changes and errors.
Sensitivity analysis is a technique for establishing the signicance of a parameter and how
it impacts the dynamics of the model. An independent variable will impact a particular
dependent variable if the variable is a dierentiable function of that parameter [12, 74].
Sensitivity analysis is a very useful tool for characterizing the uncertainty associated with
a parameter with regard to model conclusions. Its importance is part and parcel of good
modelling practice and requires a modeller to provide an evaluation of condence in the
model results. Furthermore, it validates the relevance of the inputs by determining the
output of the model [74, 99].
Uncertainty analysis may be used to asses the variability in the outcome variable that
is due to the uncertainty in estimating the input values. Sensitivity analysis can extend
uncertainty analysis by identifying important parameters that yield reliable predictions [7].
An alternative sensitivity analysis design, for a K parameter model, is to x the values
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of K − 1 parameters and then vary only the value of the Kth parameter over a specied
range. This sensitivity analysis design has the advantage that it is simple and quick, but
suers from major disadvantages. That is only one parameter may be varied at a time,
only a small region of a K−dimension parameter space can be explored and values of K−1
parameters have to be estimated [7].
Latin Hypercube Sampling (LHS) is the type of stratied Monte Carlo sampling and may
be viewed as an extension of the Latin Square sampling. In LHS, the uncertainty estimation
for each input parameter is modelled by treating each input parameter as a random variable.
It is an extremely ecient sampling design because is used only once in the analysis. An
input vector is generated for each computer simulation of the deterministic model and the
model is then run N times [7, 74].
A distribution function for each of the outcome variable can be directly derived because
of the probability selection technique. LHS enables the results of a deterministic model to
be interpreted within a statistical framework. The distribution may be characterized by
simple descriptive statistics. Sensitivity analysis may be then be performed by calculating
the partial rank correlation coecients (PRCC) for each input parameter and each outcome
variable [7, 75].
The LHS/PRCC technique involves seven steps [7]:
(a) Dening the probability distribution function for parameters and state variables. A
mathematical model contains a certain number of parameters and state variables, the
estimated values for all or only a subset of these will be uncertain.
(b) Calculating the number of simulations (N). The LHS design involves sampling without
replacement. Therefore if only k draws are made (where k equals the number of
uncertain variables), the kth draw would be predetermined. Hence the lower limit to
the value of N (where N equals the number of simulations) should be at least (k + 1).
(c) Dividing the range of each of the K parameters into N equal probable intervals. The
range of each parameter is divided into N non-overlaping equiprobable intervals (where
N is the number of simulations) and each interval is sequentially assigned a sampling
index.
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(d) Creating the LHS table. The LHS design involves random sampling without replace-
ment and every equiprobable interval of each input variable is sampled once.
(e) Sampling the values of the input parameters and performing the N simulations. The
LHS table is used to generate for example 100 by 30 input matrix.
(f) Analysing model outcomes of uncertainty analysis. The results of the simulation runs
of the model consist of N observations of each outcome variable. Distribution functions
of each outcome variable can be directly derived and characterized by simple descriptive
statistics.
(g) Analysing the model outcome with respect to the N observations of each outcome
variable which may be used to assess the sensitivity of the outcome variables and to
estimate the uncertainty of the input parameters.
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A within host model of blood stage
malaria
4.1 Introduction
Malaria parasites are transmitted from a mosquito to a human host. Upon entering the
human host, extracellular malaria sporozoites must rst take up residence in the liver
before initiating red blood cell infection. In the liver, the sporozoites undergo spectacular
phenotypic changes prior to multiplication [37, 69]. The sporozoites mature into schizonts
which rapture and release merozoites [11], which are fully competent to infect red blood
cells and instigate the pathology associated with malaria [83].
Several studies on the innate immune response to malaria infection have been formulated
[13, 65, 84, 89]. A study by Su et. al [84] on the synchronization of parasite replication
in dierent red blood cells, considers an age-structural human malaria infection of red
blood cells. The numerical simulation results in that study showed that synchronization
with regular periodic oscillation occurs when the replication rates increase. A more recent
study by Niger and Gumel [65] has investigated the innate immune response to malaria
infection and the eect of imperfect vaccines assuming a scenario of parasite life cycles.
The simulation results [65] showed that a vaccine ecacy of at least 87% is necessary to
eliminate Infected Red Blood Cells (IRBCs )in vivo.
As a sequel to these studies [5, 55, 65], we consider two stages of the parasite cycle namely (i)
22
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stage 1: A short stage when merozoites are released from the liver to initiate the red blood
cell infection. It is estimated that a primary infusion of 104 to 105 parasites are released
into the blood [55]. (ii) stage 2: The red blood stage during which asexual multiplication
of merozoites and infection of red blood cells by the merozoites occurs concurrently. Our
model does not include the early stages of the exo-erythrocytic cycle which is known to be
a reservoir for the erythrocytic stage [59]. Despite this, the results of this model can still
contribute towards understanding the replicative dynamics of the parasite and hence the
development of clinical malaria.
In-host mathematical models are important and necessary to enhance our understanding
of the dynamics of Malaria pathogenesis [58]. Such models can also be used to give insight
into the eectiveness of drug treatment and other intervention strategies [65]. In this
Chapter, we investigate the dynamics of the malaria parasite during the red blood cycle.
Our model includes the red blood cells, extracellular parasites, intracellular parasites and
eector cells. This model diers from the models in the earlier studies [5, 34, 55, 65] in that
we introduce a class of intracellular parasites in the pathogenesis process. We believe it is
important to include this process in the dynamics so that intervention strategies can be
targeted at dierent stages of the replication process as is the case in HIV/AIDS treatment
[38]. Our study addresses the following questions: (i) what replicative characteristics oer
the parasite opportunities to evade the host immune system? (ii) A signicant number
of individuals in sub-Sahara Africa are co-infected with viral (for example HIV, simian
immunodeciency virus (SIV)), bacterial and parasitic infections other than malaria [38, 42,
88, 104], it is important to investigate how such individuals respond to a malaria infection.
Studies by Kalia et el [39] and Zhang et el [104] have shown that in hosts suering from
chronic infections, CD8 T-cell functions are compromised and are dysfunctional . To give
insight into what happens when CD8 T-cell responses have been altered and impaired, we
shall consider a hypothetical situation where a host is infected with the malaria parasite
which would clear if CD8 T-cell responses were normal. We shall then alter the CD8 T-
cell response parameters m and ktp at time t < tc, where, tc is the time of clearance of
the malaria infection, and investigate the prognosis of the malaria disease by nding the
critical eector cell killing rate which must be maintained (or exceeded) to ensure that the
parasite does not establish itself within the host?
Malaria can be managed with proper diagnosis and prompt treatment . Early diagnosis and
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prompt treatment are the principle technical components of the global strategy to control
malaria. This strategy is highly dependent on the drug ecacy. Eective anti-malarial
drugs not only reduce mortality and morbidity of malaria but also reduce the risk of drug
resistance of the parasites toward available anti-malarial drugs [90].
Our model includes the replication of the parasite within the infected red blood cells.
While the process of entry into the red blood cells by the merozoites has been extensively
studied, the replication process of the parasite within an infected red blood cell is not well
understood. In this study, we have assumed a replication law for intracellular parasite
similar to that of the tuberculosis bacteria in macrophages [25]. This assumption may
not be an accurate representation of the malaria parasite replication law, however, we
have utilized the available data [18] to ensure that parasite replication in a red blood
cell produces between 8 to 32 merozoites. Using this information, we have determined
the rate of bursting, kb, for infected red blood cells taking the cell's carrying capacity
to be 32. Furthermore, we have assumed that the release of the merozoites is through
bursting of the infected red blood cell as is the case for bacteria in macrophages [25]. We
have made this assumption because very little is known about the actual parasite release
mechanism involved. We believe, however, that this study will stimulate experimental
biologists into investigating the reproductive law for intracellular malaria parasites and
the release mechanism of parasites from infected red blood cells.
We also extend the model to investigate the ecacy level required to clear the parasites.
We introduce treatment with a drug of constant ecacy 1 targeting the infection terms
[71].
4.2 Methodology
4.2.1 Model formulation
The system of equations describing the dynamics of in-host malaria is given below: The
model represents the human blood stage of the malaria disease called the erythrocytic
cycle.
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FIG. 4.1. A diagrammatic representation of within host malaria model.
TABLE. 4.1. The table with the variables, descriptions and units.
Variables Descriptions Units
R Susceptible red blood cell cell/ml
Rl Latent red blood cell cell/ml
Ra Activated red blood cell cell/ml
Pi Intracellular parasites cell/ml
Pe Extracellular parasites cell/ml
E Eector cell cell/ml
Red blood cells (RBCs)
R˙ = Sr − µrR− kRPe. (4.1)
Stellenbosch University http://scholar.sun.ac.za
Chapter 4. A within host model of blood stage malaria 26
TABLE. 4.2. The table that shows parameters and their descriptions.
Parameter Descriptions Units
Sr Constant sources of red blood cell cell/ml.day
µr Natural death rates of susceptible RBCs day
−1
k Infection rate ml/cell.day
α Proportion of RBCs dimensionless
γ Rate of activation day−1
µrl Natural death rate of latent RBCs day
−1
m Rate of killing activated RBCs by eector cell ml/cell.day
kb Rate of bursting day
−1
µra Natural death rates of activated RBCs day
−1
N Number of parasites that ll the RBCs dimensionless
kpi Rate of growth of intracellular parasites day
−1
k11 Rate of loss due to burst of activated cell day
−1
n1 A threshold number of intracellular parasites released
as a results of the natural death of an activated RBC dimensionless
ktp Rate of loss of extracellular parasites that are killed
by eector cells ml/cell.day
n∗k∗ Threshold number as a results of gain due to infection
of susceptible RBC by extracellular parasites ml/cell.day
µpe Natural death rate of extracellular parasites day
−1
ωe Growth rate of eector cells day
−1
re Carrying capacity of eector cell cell/ml
Spe Source of extracellular parasites cell/ml.day
During the human blood stage, the sporozoites injected into the human host by the female
anopheles mosquito enter the blood stream and infect susceptible red blood cells (RBCs).
The dynamics of the susceptible red blood cell (RBC) population are given in (4.1). The
terms in this equation have the following meaning: The rst term represents a constant
natural source for the red blood cell population. The second term represents natural death
of the susceptible red blood cells at a constant rate µr and the third term represents
infection of RBCs by extracellular parasites (merozoites) at a constant rate k. The newly
infected red blood cells may become latently infected with the malaria parasite, a state
which inhibits parasite replication, or the RBCs may become actively infected, meaning
that parasite replication persists in them. The rate of change for the latently infected red
blood cell population, Rl, is given by equation (4.2)
R˙l = αkRPe − (γ + µrl)Rl. (4.2)
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The terms in this equation have the following meaning: The rst term represents a propor-
tion of infected RBCs that have become latently infected, and the second term represents
losses due to activation at a constant rate γ and due to natural death at a constant rate µrl.
The actively infected red blood cell population evolves according to the following equation
(4.3) below:
R˙a = (1− α)kRPe + γRl −mERa − kbRa
(
Pi
2
Pi
2 + (NRa)2
)
− µraRa. (4.3)
The rst term in equation (4.3) represents the proportion of susceptible red blood cells
that become actively infected, the second term represents gain due to activation of latently
infected red blood cells, Rl, the third term represents the removal of activated infected
RBCs due to killing by eector cells. When the merozoites infect red blood cells, they
start to replicate within the infected red blood cells. This process can go on until the
number of parasites within the infected red blood cell reaches 32 [55] causing it to burst.
The fourth term measures an eective number of infected red blood cells that burst to
release intracellular parasite. The bursting rate in this model is assumed to be dependent
on the densities of intracellular parasites and infected red blood cells [25, 28]. This bursting
law has been used for pathogens such as TB [25]. To the best of our knowledge this has not
been used for malaria and is not supported by any literature. Not all infected red blood
cells burst to release parasite. There is an eective number of infected red blood cells that
burst to release parasite into the blood stream. The factor;
P 2i
P 2i + (NRa)
2
,
measures the proportion of infected red blood cells that burst to release parasite. We
have chosen this ratio so that the replication process has an upper bound.
This law has revealed correct replicative dynamics for the TB bacteria [25] and
is adopted in this study. The fth term accounts for natural death of infected red blood
cells at a constant rate µra.
Parasites
Intracellular parasites replicate inside an infected red blood cell. It is assumed in this study
that the intracellular parasite population grows according to a law similar to the growth of
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TB bacteria in macrophages [25]. In the absence of experimentally or clinically determined
growth law for the intracellular malaria parasite, we assume a growth law of intracellular
parasites inside an infected red blood cell of the form.
P˙i = kpiPi
(
1−
Pi
2
Pi
2 + (NRa)2
)
+ k∗n∗RPe − k11NRa
(
Pi
2
Pi
2 + (NRa)2
)
−n1µraPi. (4.4)
In equation (4.4), the rst term represents the growth of intracellular parasites. The second
term represents gain of Pi due to infection of susceptible RBCs by extracellular parasites
(merozoites), Pe, at a threshold n
∗k∗, the third term represents an eective number of
intracellular parasites lost due to bursting of activated RBCs and the forth term represents
loss of intracellular parasites due to natural death of an infected red blood cell, Ra, where
n1 denotes a threshold number of intracellular parasites released. Upon bursting of an
actively infected red blood cell, it releases the merozoites into the blood stream to continue
the parasite cycle.
kpiPi
(
1−
P 2i
P 2i + (NRa)
2
)
= kpiPi
(
(NRa)
2
P 2i + (NRa)
2
)
.
This term has the following characteristics;
lim
Ra→0
kpiPi
(
(NRa)
2
P 2i + (NRa)
2
)
= 0.
There is no growth of intracellular parasites.
lim
Ra→∞
kpiPi

 1(
Pi
NRa
)2
+ 1

 = kpiPi.
In this case the intracellular increases exponentially. As Pi → ∞ the number of bursting
infected red blood cells decreases and the loss of infected red blood cells may be
exponential. The author is not aware of the replication law for malaria parasite hence,
the replication law chosen here is similar to that for infection of macrophages by TB
bacteria [25]. This is at best an approximation which needs further investigation. The
fth term represents loss due to natural death at a constant rate µra.
Upon bursting of the actively infected red blood cells, the merozoites are released into the
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blood stream to continue the parasite cycle. The rate of change of the merozoite population
is described by equation by (4.5):
P˙e = SpePe + k11NRa
(
Pi
2
Pi
2 + (NRa)2
)
+ n1µraPi − ktpNEPe
−k∗n∗RPe − µpePe. (4.5)
The rst term in (4.5) represents the amount of extracellular parasites present in the
blood stream, the second and third terms in (4.5) represent gains of extracellular parasite
population due to bursting of activated RBCs and natural death of activated infected red
blood cells, Pi, the forth term is the loss due to killing of extracellular parasites by eector
cells, the fth term is loss due to infection of susceptible RBCs by merozoites and the sixth
term is the natural death of merozoites at a constant rate µpe.
Eector cells
Eector cells are fully dierentiated structural lymphocyte cells that are specialized in
initiating and eecting an immune response. This population includes CD4+ T-cells, and
CD8+ T-cells and is assumed to grow logistically [9] as shown in equation (4.6)
E˙ = ωe
(
1−
E
re
)
E, (4.6)
where ωe denotes the constant growth rate of this population and re is the carrying ca-
pacity of the eector cells per millilitre of blood. We have simplied the dynamics of this
population but we believe we have captured the biological role of these cells.
Positivity of the solutions
Lemma 1 Let R(0) ≥ 0, Rl(0) ≥ 0, Ra(0) ≥ 0 Pi(0) ≥ 0, Pe(0) ≥ 0 and E(0) ≥ 0. Then,
the solution (R(t), Rl(t), Ra(t), Pi(t), Pe(t), E(t)) are all non negative for all time t > 0 in
the region
Γ6 = (R,Rl, Ra, Pi, Pe, E) R
6
+. (4.7)
Proof 1 Consider the susceptible RBCs dynamics given by equation (4.1):
dR
dt
= Sr − µrR− kRPe.
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Multiplying equation (4.1) by the integration factor e(k
∫ t
0
Pe(s)ds+µrt)
, and rearranging, we
obtain
d
dt
(
R(t)e(k
∫ t
0
Pe(s)ds+µrt)
)
= Sre
(k
∫ t
0
Pe(s)ds+µrt),
R(t1) = e
(−k
∫ t1
0
Pe(s)ds−µrt)︸ ︷︷ ︸
≥0

R(0)︸︷︷︸︸︷︷︸
≥0
+Sr ×
∫ t1
0
e(k
∫ t
0
Pe(s)ds+µrt)︸ ︷︷ ︸
≥0
ds


≥ 0, As t −→∞
Now, consider the dynamics of the latently infected RBCs;
dRl
dt
= αkRPe − (γ + µrl)Rl.
Multiplying equation (4.2)the integrating factor e(γ+µrl)t, we obtain;
d
dt
(
Rl
(
e(γ+µrl)t
))
= αkR(t)Pe(t)e
(γ+µrl)t,
Rl(t1) = e
(−(γ+µrl)t1)
(
Rl(0) + αk
∫ t1
0
Rl(s)Pe(s)e
(γ+µrl)sds
)
≥ 0 As t1 −→∞.
The equation for activated infected RBCs gives;
dRa
dt
= (1− α)kRPe + γRl −mERa − kbRa
(
Pi
2
Pi
2 + (NRa)2
)
− µraRa,
≥ (1− α)kRPe + γRl − (mE + µra + kb)Ra,
= (1− α)kRPe + γRl − (mE + µra + kb)Ra.
Multiplying through by the integrating factor e(m
∫ t
0
E(s)ds+(µra+kb)t), gives:
d
dt
(
em
∫ t
0
E(s)ds+(µra+kb)t
)
Ra ≥ (1− α)kR(t)Pe(t)e
m
∫ t
0
E(s)ds+(µra+kb)t.
Ra(t1) ≥ Rae
(−m(
∫ t1
0
E(s)ds+(µra+kb)t1))
+ (1− α)ke(−(m
∫ t1
0
E(s)ds+(µra+kb)t1))
×
∫ t1
0
Ra(v)Pe(v)e
(m
∫ v
0
E(p)dp+(µra+kb)v)dv,
≥ 0 As t1 −→ ∞.
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A similar analysis for the intracellular parasite gives;
dPi
dt
= kpiPi
(
1−
Pi
2
Pi
2 + (NRa)2
)
+ k∗n∗RPe − k11NRa
(
Pi
2
Pi
2 + (NRa)2
)
−n1µraPi,
≥ k∗n∗RPe − k11NRa
P 2i
P 2i + (NRa)
2
− n1µraPi,
≥ k∗n∗RPe − k11NRa − n1µraPi.
= k∗n∗RPe − (k11 + n1µraPi) .
Multiplying through by the integrating factor is e(k11+n1µra)t, we obtain;
d
dt
(
Pi(t)e
(k11+n1µra)t
)
≥ k∗n∗R(t)Pe(t)e
(k11+n1µra)t
Pi(t1) ≥ Pi(0)e
(−(k11+n1µra)t1)
+k∗n∗e(−(k11+n1µra)t1)
∫ t1
0
R(s)Pe(s)e
(k11+n1µra)ds,
≥ 0 As t −→∞.
Lastly,
d
dt
(
Pe(t)e
(ktpN
∫ t
0
E(s)ds+k∗n∗
∫ t
0
R(s)ds+µpet)
)
≥ n1µraPi(t)e
(ktpN
∫ t
0
E(s)ds+k∗n∗
∫ t
0
R(s)ds+µpet)
Pe(t1) ≥ Pe(0)e
−ktp
∫ t1
0
E(s)ds−k∗n∗
∫ t
0
R(s)ds−µpet
+n1µrae
(−ktp
∫ t1
0
E(s)ds−k∗n∗
∫ t
0
R(s)ds−µpet)
×
∫ t1
0
Pi(t)e
(ktpN
∫ t1
0
E(s)ds+k∗n∗
∫ t
0
R(s)ds+µpet)dt,
≥ 0 As t −→∞.
The eector cells equation is logistic, and so its solution is
E =
re
1 + Ce−ωet
As t −→∞ E −→ re
then E(0) ≥ 0.
The model equation (4.1) - (4.6) is mathematically and epidemiologically well-posed and
we proceed to consider the dynamics of the ow generated by it in Γ6.
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4.2.2 Mathematical analysis of the model
Local Stability of the parasite-free equilibrium point
The system of equations (4.1) - (4.6) has equilibrium points namely the parasite-free and
the parasite-present equilibrium points. The parasite-free equilibrium point, obtained by
setting the infected states and the parasite states to zero, that is, Rl = Ra = Pi = Pe = 0,
is given by;
x02 =
(
Sr
µr
, 0, 0, 0, 0, re
)
. (4.8)
The model equations (4.1) to (4.6), depending on parameter values, can process either a
unique parasite-present equilibrium point or multiple parasite-present equilibrium point
x03 = (R
∗, R∗l , R
∗
a, P
∗
i , P
∗
e , E
∗) ,
but analytical determination of such points is too cumbersome for a large model. Our
numerical simulation, however, will demonstrate the existence and stability of these points.
We have determined the model reproduction number by rearranging the system (4.1) to
(4.6) as in the previous model (see [93] for details). We have:
R˙l = αkRPe − (γ + µrl)Rl,
R˙a = (1− α)kRPe + γRl −mERa − kbRa
(
Pi
2
Pi
2+(NRa)2
)
− µraRa,
P˙i = kpiPi
(
1− Pi
2
Pi
2+(NRa)2
)
+ k∗n∗RPe − k11NRa
(
Pi
2
Pi
2+(NRa)2
)
−n1µraPi,
P˙e = SpePe + k11NRa
(
Pi
2
Pi
2+(NRa)2
)
+ n1µraPi − ktpNEPe − k
∗n∗RPe
−µpePe,
R˙ = Sr − µrR− kRPe,
E˙ = ωe
(
1− E
re
)
E.


(4.9)
New infections occur in the four infected classes namely the class of intracellular parasites,
extracellular parasites, latently infected red blood cells and actively infected red blood
cells. The new infections are given in the matrix below:
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F =


αkRPe
(1− α)kRPe
k∗n∗RPe
k11NRa
(
Pi
2
Pi
2+(NRa)2
)
+ n1µraPi

 .
The Jacobian DF|(x02) of F is given by
F = J(F )|(x02) =


0 0 0 αkSr
µr
0 0 0 (1−α)kSr
µr
0 0 0 k
∗n∗Sr
µr
0 0 n1µra 0

 .
The other transitions among the states are given by
V =


(γ + µrl)Rl
−γRl +mERa + kbRa
(
Pi
2
Pi
2+(NRa)2
)
+ µraRa
−kpiPi
(
1− Pi
2
Pi
2+(NRa)2
)
+ k11NRa
(
Pi
2
Pi
2+(NRa)2
)
+ n1µraPi
−Spe + ktpNEPe + k
∗n∗RPe + µpePe

 ,
and the associated Jacobian is
V = J(V )|(x02) =


(γ + µrl) 0 0 0
−γ mre + µra 0 0
0 0 −kpi + n1µra 0
0 0 0 ktpNre +
k∗n∗Sr
µr
+ µpe − Spe

 .
The product FV−1 is given by
FV−1 =


0 0 0 kαSr
µr(Nktpre+µpe+ k
∗n∗Sr
µr
−Spe)
0 0 0 k(1−α)Sr
µr(Nktpre+µpe+ k
∗n∗Sr
µr
−Spe)
0 0 0 k
∗n∗Sr
µr(Nktpre+µpe+ k
∗n∗Sr
µr
−Spe)
0 0 n1µra
n1µra−kpi
0

 .
The reproduction number is dened as the largest absolute eigenvalue of the matrix FV−1
Stellenbosch University http://scholar.sun.ac.za
Chapter 4. A within host model of blood stage malaria 34
and is given by
R02 =
√
k∗n∗n1Srµra
(n1µra − kpi) (µpeµr + k∗n∗Sr +Nktpreµr − Speµr)
=
√(
n1µra
(n1µra − kpi)
)(
k∗n∗Sr
(µpeµr + k∗n∗Sr +Nktpreµr − Speµr)
)
=
√
R∗02,
(4.10)
where
R∗02 = RomRop (4.11)
Rom =
n1µra
n1µra − kpi
, n1µra − kpi > 0. (4.12)
Rop =
k∗n∗Sr
(µpeµr + k∗n∗Sr +Nktpreµr − Speµr)
. (4.13)
The number Rop is positive if the inequality
µpeµr +Nktpreµr − Speµr ≥ 0, n1µra − kpi ≥ 0, (4.14)
is satised. This simplies to µpe + Nktpre ≥ Spe. We can summarize this information as
follows:
1. The positivity of the number R∗02 requires that n1µra−kpi > 0 and µpe+Nktpre ≥ Spe.
2. The numberR∗02 is a product of two numbers, Rop andRom, representing two processes
of the red blood cycle, the infection of red blood cells by extracellular parasites and
the asexual replication of parasites within an infected red blood cell respectively.
This product describes a host-vector nature of the process whereby an extracellular
parasite must infect a susceptible red blood cell rst, multiply asexually within the
infected red blood cell before the parasites are released to continue the red blood
cycle.
Hence, from the numbers (1, 2), we conclude that, based on the model reproduction num-
ber, clinical malaria is caused mainly by the asexual reproduction of the parasite ( Rom > 1
). According to our model, although a high number of susceptible red blood cells may be
infected by extracellular parasites, this process alone does not generate enough secondary
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infections (Rop ≤ 1) to cause clinical malaria but the high number of merozoites released
into the blood stream by the ecient asexual process is responsible for rapid depletion of
the red blood cell population resulting in anaemia. One may ask the following questions
" For what values of n1 is the model reproduction number R02 greater than one and for
what numbers n1 is it less than one? Can we nd the threshold n
∗
1 which determines the
prognosis of the disease? We address these questions in detail in the section (4.2.4) on
simulation. We can state the following stability theorem for the parasite-free equilibrium
point.
Theorem 4.2.1 The parasite-free equilibrium of the system (4.1) - (4.6) is locally stable
if µpeµr +Nktpreµr − Speµr ≥ 0, n1µra − kpi ≥ 0, and R
∗
02 < 1.
From the local stability condition we have calculated the threshold killing rate of merozoites
by the eector cells and is given by
kˆtp =
kpik
∗n∗Sr
Nreµr (n1µra − kpi)
−
µpe
Nre
.
If ktp > kˆtp, the immune cells manage to control the parasite population. In malaria
endemic areas of the developing countries where many individuals suer from chronic in-
fections and their eector cell responses can be altered and impaired, the eector cells
killing rate for some patients may be below kˆtp as a results of cell fatigue [94]. This sit-
uation may be responsible for the recurrence of malaria. Note that the threshold killing
rate, mˆ, of actively infected red blood cells by eector cells cannot be determined from
the stability conditions of the parasite-free equilibrium point. We investigate the impact
of the parameter m in section (4.2.4) on simulation.
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4.2.3 A within host treatment model of blood stage malaria
Treatment with a drug of constant ecacy (1) can be incorporated in the model (4.1) -
(4.6) by inserting the factor (1− 1) next to the infection terms as shown below:
R˙ = Sr − µrR− k(1− 1)RPe,
R˙l = αkR(1− 1)Pe − (γ + µrl)Rl,
R˙a = (1− α)kR(1− 1)Pe + γRl −mERa − kbRa
(
Pi
2
Pi
2+(NRa)2
)
− µraRa,
P˙i = kpiPi
(
1− Pi
2
Pi
2+(NRa)2
)
+ k∗n∗R(1− 1)Pe − k11NRa
(
Pi
2
Pi
2+(NRa)2
)
−n1µraPi,
P˙e = SpePe + k11NRa
(
Pi
2
Pi
2+(NRa)2
)
+ n1µraPi − ktp
(
1 + 1
1+1
)
NEPe
−k∗n∗R(1− 1)Pe − µpePe,
E˙ = ωe
(
1− E
re
)
E.


(4.15)
The reproduction number calculated as in [93] is given by
R04 =
√
k∗n∗n1(1−1)Srµra
(n1µra−kpi)(H3µr)
=
√(
n1µra
(n1µra−kpi)
)(
k∗n∗(1−1)Sr
(H3µr)
)
=
√
R∗04.
where
H3 = ktp
(
1 +
1
1 + 1
)
Nre +
k∗n∗(1− 1)Sr
µr
+ µpe − Spe. (4.16)
and
R∗04 =
(
n1µra
n1µra − kpi
)(
k∗n∗(1− 1)Sr
(H3µr)
)
. (4.17)
The number R∗04 consists of two parts,
(
n1µra
(n1µra−kpi)
)
and
(
k∗n∗(1−1)Sr
H3µr
)
. These parts de-
ne the infection process which starts with the infection of red blood cells (the part(
k∗n∗(1−1)Sr
H3µr
)
) and the asexual reproduction of the parasite (
(
n1µra
(n1µra−kpi)
)
).
Note that; (
k∗n∗(1− 1)Sr
H3µ
)
< 1,
(
n1µra
(n1µra − kpi)
)
> 1. (4.18)
The ecacy parameter 1 ranges between 0 and 1. As 1 −→ 1, R
∗
04 −→ 0, and as 1 −→ 0,
R∗04 = R
∗
02. We want to determine, in the section on simulation, the least ecacy level
∗1 < 1 for which the disease clears. We can summarize the local stability of the parasite-
Stellenbosch University http://scholar.sun.ac.za
Chapter 4. A within host model of blood stage malaria 37
free equilibrium point in the following theorem:
Theorem 4.2.2 The model (4.15) is stable for R∗04 < 1, implying that treatment main-
tains the stability of the model.
4.2.4 Simulations of the within host model of blood stage malaria
Sensitivity and uncertainty analysis of R02 and parameter estimation
The model (4.1) - (4.6) requires several input parameter values, which can be divided into
three sets, namely (i) those that have been measured clinically or experimentally [TABLE
4.3], (ii) those that have been estimated by other researchers [TABLE 4.3] and (iii) those
that have been estimated by us using the parameters in (i) and (ii) above. Since a number of
parameters are not known [TABLE 4.3], we begin by investigating the level of uncertainties
TABLE. 4.3. The table that shows the parameter values of the model.
Parameter Value Source
Sr 2.5 ∗ 10
8 < Sr < 2.5 ∗ 10
9
Estimated [89, 101]
µr 0.01 [101]
k 2 ∗ 10−9 [89]
µrl 0.022 < µrl < 0.01 Estimated [5, 101]
µra 0.014 < µra < 0.02 [101]
N 32 [55]
n1 12 < n1 < 32 Estimated [55]
n∗k∗ 10−8 Estimated
k11 0.01 Estimated
kb 0.05 < kb < 0.4 Estimated
µpe 0.0208 [89]
γ 0.0001 < γ < 0.04 Estimated
α 0.2 Estimated
m 10−8 [5, 89]
kpi 0.08745 Estimated
ktp 0.01 Estimated
re 4000 < re < 15000 [100]
ωe 0.04 Estimated
Spe 0 < Spe < 50 Estimated [78]
in the model parameters and their sensitivity using Latin Hypercube Sampling Techniques
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FIG. 4.2. A diagram showing sensitivity of various parameters on the reproduction number.
[32]. The partial rank correlation coecients plotted in FIG. 4.2 show the impact of the
various parameters on the reproduction number R02. We can see that the reproduction
number is highly positively correlated to kpi, the rate of growth of intracellular parasites,
and highly negatively correlated to µra, the natural death rate of intracellular parasites
and n1 another intracellular parasite related parameter. The range of the parameter n1
is known and is given in [55]. The parameter µra is also known and is given in [101].
The parameter kpi has not been estimated clinically or experimentally and is estimated
in this study using the parameters from McQueen and McKenzie [55] and the references
therein. Using the values in [TABLE 4.3], we have found using an iterative procedure that
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n1 = 16 is the threshold value for which R02 = 1. Using this value of n1 and the parameter
values in [TABLE 4.3], we have estimated the value of the growth rate of parasites to be
kpi = 0.08745.
We want to use the parameters in [TABLE 4.3] to study the following hypothetical prob-
lems: (a) First, from the model equations (4.1) - (4.6), we want to determine the number,
n1, of merozoites in an infected red blood cell at the time of its natural death for which
R02 < 1, and for which R02 > 1. In other words, we want to use the threshold value
n∗1 = 16 (R02 = 1), to determine the prognosis of the malaria disease. (b) Secondly,
while acute infections usually result in eective immune responses, chronic infections are
associated with suboptimal eector cell responses [94]. To illustrate this, we consider a
hypothetical situation where a host has malaria infection which would clear if CD8 T-cell
responses were normal (that is R02 < 1). We then alter the CD8 T-cell response param-
eters m and ktp at time t < tc, where tc is the time of clearance of the malaria infection,
and investigate the prognosis of the disease. (iii) The malaria extracellular parasites are
generated either by bursting of infected RBCs or by natural death of infected red blood
cells. We investigate which of these replication mechanisms is responsible for the develop-
ment of clinical malaria.
4.2.5 Simulations of the within host treatment model of blood
stage malaria
The models equations (4.15) require several input parameter values, which can be divided
into three sets, namely (i) those that have been measured clinically or experimentally
[TABLE 4.4], ( ii) those that have been estimated by other researchers [TABLE 4.4], and
(iii) those that have been estimated by us using the parameters in (i) and (ii) above. We
used MATLAB routines ODE45, ODE15s etc, to analyse our system and the sensitivity
analysis for estimation of parameter on [TABLE 4.4] was done in section 4.2.4 and is not
repeated here. We have included [TABLE 4.4] here to make referencing easier. The time
used from simulations is zero to 60 days, which, clinically, is the time for an infected person
to shows symptoms of malaria. In this example, we have started treatment on 32 day after
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TABLE. 4.4. The table that shows the parameter values of the model.
Parameter Value Units Source
Sr 2.5 ∗ 10
7.2 cell/ml.day Estimated [5, 55]
µr 0.01 day
−1
[101]
k 2 ∗ 10−9.5 ml/cell.day [5, 89]
µrl 0.008 day
−1
Estimated [5, 101]
µra 0.014 day
−1
[101]
N 32 dimensionless [55]
n1 12 dimensionless Estimated [55]
n∗k∗ 10−8 ml/cell.day Estimated
k11 0.01 day
−1
Estimated
kb 0.4 day
−1
Estimated
µpe 0.0208 day
−1
[89]
γ 0.0001 day−1 Estimated
α 0.2 dimensionless Estimated
m 10−8 ml/cell.day [5]
kpi 0.08745 day
−1
Estimated
ktp 0.0009 ml/cell.day Estimated
µpe 0.0208 day
−1
[89]
re 880 cell/ml [100]
ωe 0.05 day
−1
Estimated
Spe 20 cell/ml.day Estimated [78]
1 0 < 1 < 0.95 dimensionless Estimated
initial infection. This is because, the average time for clinical symptoms to appear is
between (8− 25) days but it can take longer depending on the immune system of the host
[48].
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4.3 Results of the within host model of blood stage
malaria
Dynamics of the system
FIG. (4.3) shows the time plots for the various classes of human cells and parasite classes
for R02 = 0.8327 As expected the susceptible red blood cell drops initially but settles at a
stead state level which is high enough to sustain life. All the infected states tend to zero
and the disease does not establish itself. FIG. 4.4 shows a time plot for all the human
cell populations and the parasite populations for R02 = 1.3165. It is clear that the disease
establishes itself. The level of red blood cells falls rapidly below a level sucient to support
life.
Figures 4.5 and 4.6 show the evolution of the intracellular (FIG. 4.5) and extracellular
(FIG. 4.6) parasites for various values of the parameter n1 ( 8 ≤ n1 ≤ 32) and the corre-
sponding reproduction numbers. These gures, surprisingly, show that the replication of
intracellular and extracellular parasites in the host is fastest for n1 = 8. At this level of
replication, each merozoite released from an infected red blood cell generates on average
1.6679 secondary infections. The replication of extracellular and intracellular parasites
decreases as n1 increases. Likewise, the reproduction number decreases as n1 increases
(FIG. 4.5 and FIG. 4.6). We can see from these plots that the parasite persists for n1 < 16
possibly resulting in clinical malaria but fails to invade the host for n1 ≥ 16 provided the
eector cell functions are normal. The fact that the parasite persists for small values n1
suggests that the increase in the merozoite population within the host does not depend on
the bursting of the infected red blood cells (lled to cell capacity, that is, N = 32) but on
the natural death of infected red blood cells. FIG. 4.7, which is typical for other values
of n1, illustrates the relative impact of the two merozoite replication mechanisms namely,
replication by bursting of infected red blood cells, P1, for N = 32 and replication by natural
death of infected red blood cells, P2, for the case n1 = 12. It is clear from (FIG. 4.7) that
replication by natural death of infected red blood cells contributes signicantly more than
replication from bursting of infected red blood cells thereby conrming our earlier asser-
tion. We are led to conclude that the merozoites may have preference for infecting older
susceptible red blood cells that do not have a long time left to live. Figures (4.8 and 4.9)
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FIG. 4.3. Shows a diagram of parasite-free equilibrium with R02 = 0.8327.
show the evolution of red blood cell and infected red blood cell populations respectively.
The population of red blood cells declines rapidly while the infected red blood cell popu-
lation increases to a peak before going down. The peak of the infection, measured by the
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FIG. 4.4. A diagram of parasite-present equilibrium with R02 = 1.3165.
level of infected red blood cells, occurs approximately 37 days after the infection started,
which agrees with clinical data [91, 96]. For n1 < 16 the infection never clears and the
red cell steady state level is only 25%− 40% (FIG. 4.10) of the parasite-free level,a which
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A plot of intracellular parasites vs time
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FIG. 4.5. A diagram showing population of intracellular parasites for n1 < 16 the parasite-
present equilibrium cases and n1 ≥ 16 the parasite-free equilibrium cases.
is too low to sustain life. Clearly, for n1 < 16 treatment with malaria drugs is the only
means of controlling the malaria parasite. The results for n1 ≥ 16 show that the parasite
clears from the host as illustrated in FIG. 4.11 and FIG. 4.12. These gures show that the
activated and latently infected red blood cell populations become extinct. For n1 = 16,
FIG. 4.10 shows that after the infection has cleared the red cell steady state level is 80%
of the parasite-free level which is high enough to sustain life. However, for individuals
with chronic illnesses [22, 72, 81, 104], the eector cell functions can be compromised. To
illustrate this, we consider a malaria infection which under normal eector cell function
would lead to a parasite-free equilibrium state and investigate the eect of reducing the
role of eector cells by decreasing the parameters ktp and m. Taking the state variables at
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A plot of extracellular parasites vs time
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FIG. 4.6. A diagram showing population of extracellular parasites for n1 < 16 the parasite-
present equilibrium cases and n1 ≥ 16 the parasite-free equilibrium cases.
time t = 350 and decreasing the parameters ktp and m, we notice that the population of
activated red blood cells (FIG. 4.13) immediately increases while the susceptible red cell
population (FIG. 4.14) declines. We conclude that if the role of the eector cells is reduced
even for the case n1 = 24 the host would develop malaria.
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FIG. 4.7. Represents relative impact of the two parasite production mechanisms 10 ∗ P1
and (P2) for n1 = 12 and R02 = 1.1277.
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FIG. 4.8. A diagram showing the evolution of RBCs with time.
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FIG. 4.9. A diagram showing the evolution of active infected RBCs with time.
Stellenbosch University http://scholar.sun.ac.za
Chapter 4. A within host model of blood stage malaria 48
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
x 109
0
5
10
15
x 108
Susceptible red blood cell
A
ct
iv
e 
in
fe
ct
ed
 r
ed
 b
lo
od
 c
el
l
Contour plot of active infected RBCs vs susceptible RBCs
n1=15
n1=12
n1=16
FIG. 4.10. Contour plots for n1 = 12 and n1 = 15 and n1 = 16.
0 100 200 300 400 500
0
2
4
6
8
10
x 104
Time (days)
Ac
tiv
e i
nfe
cte
d R
BC
s
A plot of active infected RBCs vs time
FIG. 4.11. Shows the population of actively infected RBCs at for n1 = 24.
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FIG. 4.12. Shows the population of latently infected RBCs at for n1 = 24.
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FIG. 4.13. Diagram showing the population of actively infected RBCs population for
dierent values of m and ktp.
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FIG. 4.14. Diagram showing the population of susceptible RBCs population for dierent
values of m and ktp.
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4.4 Results of within host treatment model of blood
stage malaria
FIG. (4.15) shows that susceptible red blood cell population decreases between day 20
and day 50 in the absence of treatment. The latently and actively infected red blood cell
population increase during the same period.
The FIG. 4.16 shows plots when treatment is administered for drug ecacies ranging from
(1 = 0) to (1 = 0.95). the gure shows that the depletion of the susceptible red blood
cell population decreases with increasing ecacy. On the other hand the latently and
actively infected red blood cell populations decrease with increasing ecacy. Intracellular
parasites decrease with increasing ecacy while extracellular parasites increase and show
the same characteristic as time increases. the reproduction number is a decreasing function
of ecacy from R04 = 1.3723 for 1 = 0 to R04 = 0.5074 for 1 = 0.95. .
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FIG. 4.15. A diagram shows malaria without treatment.
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FIG. 4.16. Diagram showing one type of drug in treatment of malaria after 32 days and
1 = 0 =⇒ R04 = 1.3723, 1 = 0.4 =⇒ R04 = 1.2114, 1 = 0.6 =⇒ R04 = 1.0932,
1 = 0.95 =⇒ R04 = 0.5074.
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4.5 Discussion
Sensitivity and uncertainty analysis has shown that the reproduction number is highly
sensitive to the rate of growth of intracellular parasites (kpi). An overestimate or under-
estimate of this parameter has serious implications regarding the prognosis of the disease.
Therefore, there is need for a clinical or experimental determination of this parameter in
particular but also a number of other parameters, such as rate of loss of extracellular par-
asites that are killed by eector cells (ktp), threshold number as a results of gain due to
infection of susceptible RBC by extracellular parasites (n∗k∗), rate of loss due to burst of
activated cell (k11), rate of bursting (kb), rate of activation (γ), proportion of RBCs (α),
to enhance the understanding of malaria.
We have found that parasites are replicated in two ways: (i) from naturally dying infected
red blood cells and (ii) from bursting of infected red blood cells lled to carrying capacity
N. Of the two mechanisms, we have found that natural death of infected red blood cells
contributes more to the population of extracellular parasites. Interestingly, the number of
parasites in a dying infected red blood cell need not be high for clinical malaria to develop.
In fact the larger the number of parasites in a dying infected cell the smaller the chances
of clinical malaria developing. Furthermore, we have found the following link between a
threshold number of intracellular parasites released as a results of the natural death of an
activated RBC (n1) and the reproduction number R02 : For n1 < 16, R02 > 1 and for
n1 ≥ 16, R02 ≤ 1. This result suggests that the larger n1 is, the longer it takes to produce
the parasites and the higher the chance of an infected red blood cell being identied and
apoptosised by the eector cells. This has led us to conclude that in order to minimize the
possibility of infected red blood cells being detected and eliminated by the immune cells,
the parasite has a strategy of infecting older red blood cells whose life expectancy is much
shorter than the younger cells [55] and in this way avoid the infected red blood cell being
detected and apoptosised.
The reproduction number (4.10) is a product of two reproduction numbers Rop and Rom
that reveal the host-vector infection nature of the process during the erythrocytic stages.
Of the two processes namely infection of susceptible red blood cells by extracellular para-
sites and asexual production of parasites, it is the asexual replication process, measured by
Rom, which is responsible for the pathology of clinical malaria as the reproductive rate for
this process is greater than one per merozoite. To prevent clinical malaria from develop-
ing, it is important to administer highly ecacious drugs to stop the erythrocytic stage of
the parasite cycle. However, the fact that the major source of parasite production is from
naturally dying infected red blood cells has implications regarding the control of malaria as
even treatment with highly ecacious drugs could generate drug resistant malaria strains
if some infected red blood cells died before the drug chemodynamic eects are completed.
We believe that only a malaria vaccine can reliably protect against blood stage malaria
infection.
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We have also shown that chronic infections can transform manageable malaria into a more
active disease. The recommendation from our study is that in malaria endemic areas, indi-
viduals with malaria or showing malaria symptoms should be tested for chronic infections
and those who test positive for any chronic infection should be treated for both malaria and
the chronic infection.
We have investigated the eects of treatment on parasite depletion of susceptible red blood
cells by introducing a drug of ecacy 1. As a rst step, we determined the reproduction
number which is now dependent on the drug ecacy. Taking  = 0 in the formula for
R0 gives the reproduction number obtained in the model without treatment. Clearly, the
eect of the drug is apparent on the population sizes of red cells. It is found that the pop-
ulation of susceptible red blood cells increases with increasing ecacy (FIG. 4.16). The
infected red blood cell populations on the other hand decrease with increasing ecacy.
A drug of ecacy of at least 0.6 is capable of clearing the parasites (FIG. 4.16). Most
malaria treatment drugs are of higher ecacy than 0.6. It is possible to combat malaria
with treatment drugs but the administration of drugs should be done at health centres or
hospitals to ensure that patients complete their treatment. This will go a long way towards
reducing the rate of drug resistance to current malaria drugs.
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A within host treatment model with
three stages of malaria life cycle
5.1 Introduction
Malaria remains one of the most serious global health problems and it is one of the leading
causes of death and illness in children and adults in tropical countries [6, 91, 95]. Malaria
control requires an integrated approach, such as prevention which includes vector control
and treatment with eective anti-malarial drugs. The once aordable and widely available
anti-malarial treatment drug, chloroquine, that was used from the 1950's to the 1970's
is now totally ineective [6, 102, 103]. The use of ACTs is the best current treatment
strategy; unfortunately the implementation of this treatment strategy has lagged behind
due to various factors such as high cost of the drugs [95].
The malaria life cycle (FIG. 2.2), involves two hosts namely an infected female anopheles
mosquito which inoculates sporozoites into the blood circulation of a human host during
a blood meal, and the human host. Initial replication of the parasite starts in the liver
with the sporozoites infecting and invading liver cells (hepatocytes). The sporozoites then
mature into schizonts which rupture to release merozoites into the blood stream. In the
blood stream, the merozoites infect the red blood cells (RBCs) within which they undergo
asexual multiplication (erythrocytic schizogony). This stage is responsible for the devel-
opment of clinical malaria [2, 11, 41, 45, 101].
The sporogonic cycle (mosquito cycle) starts when the gametocytes (micro-gametes and
macro-gametes) are ingested by a female anopheles mosquito during a blood meal. While
in the mosquito stomach, fertilization occurs and to form zygotes. The zygotes trans-
form into ookinetes which invade the midgut wall of the mosquito where they transform
into oocysts. Oocysts grow, rupture and release sporozoites which invade mosquito sali-
56
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vary glands. When the mosquito bites a susceptible human, the mosquito life cycle starts
[11, 45, 50]. Mathematical models have been valuable decision-making tools for vacci-
nation and treatment strategies against infectious diseases. Many mathematical models
of malaria parasite pathogenesis and its transmission continue to be constructed by re-
searchers [52, 5557, 65, 84]. Most of these models focus on within-host dynamics of blood
stage malaria or cell-mediated immune response to pathogenesis. Very few researchers,
among them Miranda [87], have considered the within-mosquito parasite replication cycle.
The study by Iggidr et. al [35] considers a malaria within host model with k stages of age
for the parasitized red blood cells and n strains for the parasite. A study by Niger and
Gumel [65] has investigated the innate immune response to malaria infection and the eect
of imperfect vaccines assuming a scenario of parasite life cycles. The simulation results [65]
showed that a vaccine ecacy of at least 87% is necessary to eliminate Infected Red Blood
Cells (IRBCs )in vivo. Our model will include three stages of the parasite life cycle namely:
the exo-erythrocytic schizogony, which includes susceptible liver cells (Sl), infected liver
cells (Il), Sporozoites (P ) and Schizonts (Cl), the erythrocytic schizogony, which includes
susceptible red blood cells (R), infected red blood cells (Ri), merozoites (Mr), trophozoites
(T ), and schizonts (Cr) and the sporogonic cycle, include susceptible midgut cells (Smc),
infected midgut cells (Imc) and gametocytes (G). We shall also introduce treatment with
a drug of constant ecacy 1, and the immune response represented by the eector cells.
Despite vast clinical and experimental knowledge of the immunology of the malaria para-
site life cycle [11, 26, 45, 50], development of the vaccine for malaria is still elusive. The
development of the vaccine is as much immunological as it is epidemiological. The epi-
demiology of malaria guides the processes of development of new vaccines and treatments
[79] and implementation of the vaccine and treatment trials. Needless to say, the eective
and aordable drug that will treat all the three stages of the malaria cycle will have major
impact on global public health.
In this chapter, we formulate a model based on the schemata of the parasite life cycle
presented on the Center for Disease Control Website (FIG. 2.2).
Stellenbosch University http://scholar.sun.ac.za
Chapter 5. A within host model with three stages of malaria life cycle 58
5.2 Methodology
5.2.1 Model development
We shall use the following variables
TABLE. 5.1. The table describing the variables and units of variables
Variables Descriptions Units
Sl Susceptible liver cells cell/ml
Il Infected liver cells cell/ml
P Sporozoites cell/ml
Cl Schizonts inside liver cells cell/ml
R Susceptible red blood cell cell/ml
Ri Activated red blood cell cell/ml
Mr Merozoites cell/ml
T Trophozoites cell/ml
Cr Schizonts inside red blood cells cell/ml
Smc Susceptible midgut cells cell/ml
Il Infected liver cells cell/ml
G Gametocytes cell/ml
E Eector cells cell/ml
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TABLE. 5.2. The table describing the parameters and units of parameters
Parameter Descriptions Units
Πl Constant source of liver cells cell/ml.day
βl Infection rate ml/cell.day
µsl Natural death rate of susceptible liver cells day
−1
kl Rate of bursting of infected liver cells day
−1
N Cell carrying capacity dimensionless
m Rate of killing of infected cell by eector cells ml/cell.day
µil Natural death of an infected liver cells day
−1
Πp Source of sporozoites day
−1
βp Infection rate ml/cell.day
αp Rate of gain/loss of sporozoites day
−1
k12 Rate of bursting of infected midgut cells day
−1
n3 Average number of sporozoites release from
an infected midgut cells that dies naturally dimensionless
µimc Natural death of an infected midgut cells day
−1
µp Natural death of sporozoites day
−1
kcl Growth rate of schizonts day
−1
ktp Rate of loss of schizonts inside the liver cells
that are killed by eector cells ml/cell.day
n1 Average number of schizonts release from
an infected liver cells that dies naturally dimensionless
µcl Natural death of schizonts inside the liver cells day
−1
Sr Constant source of red blood cells (RBCs) cell/ml.day
k Infection rate ml/cell.day
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TABLE. 5.3. The table describing the parameters and units of parameters
Parameter Descriptions Units
µr Natural death of susceptible RBCs day
−1
kb Rate of loss of infected RBCs
due to bursting of infected RBCs day−1
µri Natural death of infected RBCs day
−1
kr Growth rate due to infection of RBCs day
−1
k7 Rate of killing of merozoites by eector cells ml/cell.day
k13 Rate of loss of merozoites day
−1
µmr Natural death of merozoites day
−1
γ Proportion of merozoites dimensionless
ω Rate of gain/loss of trophozoites day−1
µt Natural death of trophozoites day
−1
k11 Rate of loss of schizonts due to
bursting of infected RBCs day−1
µcr Natural death of schizonts inside RBCs day
−1
Πmc Constant source of midgut cells cell/ml.day
βmc Infection rate ml/cell.day
µmc Natural death of susceptible midgut cells day
−1
µimc Natural death of infected midgut cells day
−1
µg Natural death of gametocytes day
−1
ωe Growth rate of eector cells day
−1
re Carrying capacity of eector cell cell/ml
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Liver stage (exo-erythrocytic schizogony)
From FIG. 2.2, it is easy to see that, the model for the liver stages (exo-erythrocytic
schizogony) must include susceptible liver cells (Sl), infected liver cells (Il), Sporozoites
(P ) and Schizonts (Cl). We also introduce treatment with a drug of constant ecacy 1.
The dynamics for the susceptible liver cells is given by:
S˙l = Πl − βl(1− 1)SlP − µslSl. (5.1)
The rst term of equation (5.1) is a source for the susceptible liver cells, the second term
represents loss due to infection of susceptible liver cells by sporozoites [85] and the third
term represents natural death of susceptible liver cell at constant rate µsl . The rate of
change of the population of infected liver cells is given by:
I˙l = βl(1− 1)SlP − klIl
(
Cl
2
Cl
2 + (NIl)2
)
−mEIl − µilIl. (5.2)
The rst term in equation (5.2) is due to infection of liver cells, the second term represents
loss due to bursting of infected liver cells which is assumed to be dependent on the densities
of gametocytes and infected liver cells [28], the third and fourth terms represent losses due
lysing of infected cells by eector cells and natural death at a constant rate µil respectively.
We have assumed a bursting rate similar to that of bacteria in infected macrophages [25, 28],
an assumption which has not been conrmed clinically or experimentally for malaria.
P˙ = ΠpP − βpSlP − αpP + k12Imc
(
G2
G2 + (NImc)2
)
+n3µimcImc − µpP. (5.3)
Sporozoites enter the susceptible liver cells immediately after being inoculated into the
blood stream by the mosquito (FIG. 2.2). Within the liver cells the sporozoites develop
into schizonts [26, 45]. In equation (5.3) the rst term represents a source of sporozoites,
the second term is loss of sporozoites due to infection of liver cells, the third term is loss
due to maturity of sporozoites into schizonts, the fourth term measures the number of
infected midgut cells that burst to release gametocytes. The fth term is the gain due to
natural death of midgut cells, and the sixth term is the natural death of the sporozoites.
C˙l = αpP + kclSl
(
1−
Cl
2
Cl
2 + (NIl)2
)
− ktpNECl − n1µclCl. (5.4)
Equation (5.4) represents the evolution of liver schizonts. The rst term of the equation
represents the maturation of sporozoites into the liver schizonts [50], the second term is
growth of schizonts by an assumed law [25, 26, 28]. The third term is the loss of schizonts
lysis by eector cells, the forth term is the loss due to death of infected liver cell.
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Blood stages (erythrocytic schizogony)
Erythrocytic schizogony [45] is the blood stage of the malaria infection described in an
earlier chapter and it involves susceptible red blood cells (R), infected red blood cells (Ri),
merozoites (Mr), trophozoites (T ), and schizonts (Cr). Schizonts here are a result of the
asexual reproduction during the blood stage of the infection. The red blood cell population
evolves according to the equation below:
R˙ = Sr − k(1− 1)RMr − µrR. (5.5)
The terms in equation 5.5 can be explained as follows: The rst term represents a source
of health red blood cells from bone marrow [55] and the second term represents infection of
healthy red blood cells by merozoites. The third term represents natural death of healthy
red blood cell at a constant rate µr. An infected red blood cell is an incubator of the
parasite and as such is targeted by the eector cells as explained in equation (5.6). The
dynamics if the infected red cells is given by:
R˙i = k(1− )RMr −mERi − kbRi
(
Cr
2
Cr
2 + (NRi)2
)
− µriRi, (5.6)
The rst term of equation (5.6) represents gain by the population of infected red blood
cells due to infection of susceptible red blood cells by merozoites [26], the second term is
loss as a results of the immune response which triggers the eector cells to remove the
infected red blood cells assumed here to be at a constant rate m, the third term is loss
due to bursting of infected red blood cells. The fourth term represents natural death of
infected red blood cell at a constant rate µri. Within an infected red blood cell, we assume
a law for the evolution of the merozoites population given in equation (5.7) below:
M˙r = n1µilCl + krMr
(
1−
Mr
2
Mr
2 + (NRi)2
)
− k7EMr
−k13Mr − µmrMr, (5.7)
In equation (5.7) which represents the merozoite dynamics, the rst term represents mero-
zoites released from dying infected liver cells, the second term is logistic growth of the
merozoite population, the third term is loss due lysing of merozoites by eector cells, the
fourth term is loss as merozoites mature into trophozoites and the fth term is the natu-
ral death of merozoites at constant rate µmr. The rate of change of the trophozoites and
schizonts populations are described by equation (5.8) and (5.9)
T˙ = γk13Mr − ωT − µtT. (5.8)
In equation (5.8) which represents the trophozoites dynamics, the rst term represents a
proportion of trophozoites that mature into merozoites, the second term is loss as tropho-
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zoites mature into schizonts and the third term is the natural death of trophozoites at a
constant rate µt.
C˙r = ωT − k11NRi
(
Cr
2
Cr
2 + (NRi)2
)
− µcrCr. (5.9)
The mature trophozoites asexually divide to form schizonts [26]. In equation (5.9) which
represents the evolution of blood schizonts, the rst term represents gain due to maturity
of trophozoite, the second term is loss due to bursting of infected red blood cells, and the
third term is the natural death of schizonts at a constant rate µcr.
Mosquito stages (sporogony)
The mosquito stages (sporogonic) consist of three classes namely, susceptible midgut cells
(Smc), infected midgut cells (Imc) and gametocytes (G). The dynamics of the midgut cells
is given by:
˙Smc = Πmc − βmcGSmc − µmcSmc. (5.10)
The rst term of equation (5.10) represents a constant source of midgut cells, the second
term represents infection of susceptible midgut cells by gametocytes at a constant rate βmc,
and the third term is natural death of susceptible midgut cells at a constant rate µmc.
˙Imc = βmcGSmc − n3µimcImc. (5.11)
The rst term of equation (5.11) represents a gain due infection of susceptible midgut cells
by gametocytes at a constant rate βmc, the second term represents loss of infected midgut
cells due to death of infected mid gut cells. The dynamics of the gametocytes are explained
by equation (5.12) below:
G˙ = (1− γ)k13Mr − k12Imc
(
G2
G2 + (NImc)2
)
− µgG. (5.12)
Gametocytes are taken by the susceptible mosquito as part of a blood meal. The gameto-
cytes dynamics are represented by equation (5.12). The rst term represents a proportion
of merozoites that become gametocytes, the second term is loss due to bursting of infected
midgut cells, and third term is natural death of gametocytes at constant rate µg.
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Eector cells
The eector cells include CD4+ T-cells, and CD8+ T-cells. We have simplied the dy-
namics of this group of cells but we hope their biological role is adequately represented.
E˙ = ωe
(
1−
E
re
)
E. (5.13)
In the equation (5.13), ωe denotes the constant growth rate of this population and re is
the carrying capacity of the eector cells per millilitre of blood.
Positivity of solutions
Lemma 2 Let Sl(0) ≥ 0, Il(0) ≥ 0, P (0) ≥ 0, Cl(0) ≥ 0, R(0) ≥ 0, Ri(0) ≥
0, Mr(0) ≥ 0, T (0) ≥ 0. Cr(0) ≥ 0, Smc(0) ≥ 0, Imc(0) ≥ 0, G(0) ≥ 0, E(0) ≥ 0.
Then, the state variables in the solution
(Sl(t), Il(t), P (t), Cl(t), R(t), Ri(t), Mr(t), T (t), Cr(t), Smc(t), Imc(t), G(t), E(t)) are
all non negative for all time t > 0 in the region.
Γe = (Sl, Il, P, Cl, R, Ri, Mr, T, Cr, Smc, Imc, G, E)  R
13
+ . (5.14)
Proof 2 Consider the susceptible liver cells;
dSl
dt
= Πl − (βl(1− 1)P − µsl)Sl.
Multiplying both sides by the integration factor
(
eβl(1−1)
∫ t
0
P (s)ds+µslt
)
, we obtain:
d
dt
(
Sl(t)e
βl(1−1)
∫ t
0
P (s)ds+µslt
)
= Πle
(βl(1−1)
∫ t
0
P (s)ds+µslt)
Sl(t1) = Sl(0)e
(−βl(1−1)
∫ t1
0
P (s)ds−µslt)
+Πle
(−βl(1−1)
∫ t1
0
P (s)ds−µslt)
∫ t1
0
e(βl(1−1)
∫ t
0
P (s)ds+µslt)dt
≥ 0.
At t = 0, Sl(t) = Sl(0) ≥ 0.
As t1 −→ ∞, Sl(t) ≥ 0.
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Similarly, we can show that
Il(t1) −→ 0, P (t1) −→ 0, Cl(t1) −→ 0, R(t1) −→ 0
Ri(t1) −→ 0, Mr(t1) −→ 0, T (t1) −→ 0, Cr(t1) −→ 0
Smc(t1) −→ 0, Imc(t1) −→ 0, G(t1) −→ 0, R(t1) −→ 0
E(t1) −→ 0
As t1 −→∞. The system (5.1) to (5.13) is mathematically and immunologically well-posed
and we proceed to consider the dynamics of the ow generated by it in Γe.
5.2.2 Mathematical Analysis of the model
The analysis that follows involves deriving the equilibrium points, the reproduction number,
and establishing the stability of the equilibrium points.
Stability of parasite-free equilibrium and the reproduction number
We derive the parasite-free equilibrium points by putting the variables for infected states
equal to zero, giving;
x06 = (Sl, Il, P, Cl, R, Ri,Mr, T, Cr, Smc, Imc, G, E)
=
(
Πl
µsl
, 0, 0, 0,
Sr
µr
, 0, 0, 0, 0,
Πmc
µmc
, 0, 0, re
)
.
The model equations (5.1 - 5.13), depending on parameter values, can possess a unique
parasite present equilibrium point or multiple parasite-present equilibrium points
x07 = (Sl, Il, P, Cl, R, Ri,Mr, T, Cr, Smc, Imc, G, E)
= (S∗l , I
∗
l , P
∗, C∗l , R
∗, R∗i ,M
∗
r , T
∗, C∗r , S
∗
mc, I
∗
mc, G
∗, E∗) ,
which algebraically are too complicated to calculate for a large model. Our numerical
simulation, however, will demonstrate the existence of these points. The reproduction
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number is computed by considering the infectious states only as in the previous chapters:
I˙l = βl(1− 1)SlP − klIl
(
Cl
2
Cl
2+(NIl)2
)
−mEIl − µilIl,
P˙ = ΠpP − βpSlP − αpP + k12Imc
(
G2
G2+(NImc)2
)
+n3µimcImc − µpP,
C˙l = αpP + kclSl
(
1− Cl
2
Cl
2+(NIl)2
)
− ktpNECl − n1µclCl,
R˙i = k(1− 1)RMr −mERi − kbRi
(
Cr
2
Cr
2+(NRi)2
)
− µriRi,
M˙r = n1µilCl + krMr
(
1− Mr
2
Mr
2+(NRi)2
)
− k7EMr
−k13Mr − µmrMr,
T˙ = γk13Mr − ωT − µtT,
C˙r = ωT − k11NRi
(
Cr
2
Cr
2+(NRi)2
)
− µcrCr,
˙Imc = βmcGSmc − n3µimcImc,
G˙ = (1− γ)k13Mr − k12Imc
(
G2
G2+(NImc)2
)
− µgG.


(5.15)
From the model(5.15), the new infections are given by
F =


βl(1− 1)SlP
k12Imc
G2
G2+(NImc)2
+ n3µimcImc
αpP
k(1− 1)RMr
n1µilCl
γk13µr
ωT
βmcGSmc
(1− γ)k13Mr


,
and its Jacobian matrix at the parasite-free equilibrium is given by
F = DF|(x06) =


0 βl(1−1)Πl
µsl
0 0 0 0 0 0 0
0 0 0 0 0 0 0 n3µimc 0
0 αp 0 0 0 0 0 0 0
0 0 0 0 k(1−1)Sr
µr
0 0 0 0
0 0 n1µil 0 0 0 0 0 0
0 0 0 0 γk13 0 0 0 0
0 0 0 0 0 ω 0 0 0
0 0 0 0 0 0 0 0 βmcΠmc
µmc
0 0 0 0 (1− γ)k13 0 0 0 0


.
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The other transitions among the states are given by
V =


klIl
(
C2
l
C2
l
+(NIl)2
)
+mEIl + µilIl
−ΠpP + βpSlP + αpP + µpP
−kclSl
(
1−
C2
l
C2
l
+(NIl)2
)
+ ktpNECl + n1µclCl
mERi + kbRi
(
C2r
C2r+(NRi)
2
)
+ µriRi
−krMr
(
1− M
2
r
M2r+(NRi)
2
)
+ k7EMr + k13Mr + µmrMr
ωT + µtT
k11NRi
(
C2r
C2r+(NRi)
2
)
+ µcrCr
n3µimcImc
k12Imc
(
G2
G2+(NImc)2
)


,
with its Jacobian matrix at the parasite-free equilibrium given by
V = DV|(x06) =


Q1 0 0 0 0 0 0 0 0
0 Q2 0 0 0 0 0 0 0
0 0 Q3 0 0 0 0 0 0
0 0 0 Q4 0 0 0 0 0
0 0 0 0 Q5 0 0 0 0
0 0 0 0 0 Q6 0 0 0
0 0 0 0 0 0 µcr 0 0
0 0 0 0 0 0 0 n3µimc 0
0 0 0 0 0 0 0 0 µg


.
Where
Q1 = mre + µil, Q2 =
(
Πlβp
µsl
+ αp + µp − Πp
)
,
Q3 = Nktpre + n1µcl, Q4 = mre + µri,
Q5 = k13 − kr + µmr + k7re, Q6 = ω + µt.
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The product FV−1 is given by
FV−1 =


0 Πl(1−1)βl
Q2
0 0 0 0 0 0 0
0 0 0 0 0 0 0 1 0
0 αp
Q2
Q3 0 0 0 0 0 0
0 0 0 0 k(1−1)Sr
µrQ5
0 0 0 0
0 0 n1µil
Q3
0 0 0 0 0 0
0 0 0 0 γk13
Q5
0 0 0 0
0 0 0 0 0 ω
ω+µt
0 0 0
0 0 0 0 0 0 0 0 Πmcβmc
µgµmc
0 0 0 0 (1−γ)k13
Q5
0 0 0 0


,
The largest eigenvalue of FV−1 is called the reproduction number and is given by;
R06 =
5
√(
Πmc(1− 1)βmc
µgµmc
)(
Πlβl
Q2
)(
k(1− 1)Sr
µrQ5
)(
n1µil
Q3
)(
ω
ω + µt
)
(5.16)
R∗06 =
(
Πmc(1− 1)βmc
µgµmc
)(
Πlβl
Q2
)(
k(1− 1)Sr
µrQ5
)(
n1µil
Q3
)(
ω
ω + µt
)
(5.17)
Since 1 ranges between 0 and 1. We see that as 1 −→ 1, R
∗
06 −→ 0 and as 1 −→ 0,
R∗06 = R
∗
07 =
(
Πmcβmc
µgµmc
)(
Πlβl
Q2
)(
kSr
µrQ5
)(
n1µil
Q3
)(
ω
ω + µt
)
, (5.18)
where
R07 =
5
√
R07∗ =
5
√(
Πmcβmc
µgµmc
)(
Πlβl
Q2
)(
kSr
µrQ5
)(
n1µil
Q3
)(
ω
ω + µt
)
. (5.19)
We want to determine, in the section on simulation, the least ecacy ∗1 < 1 for which the
disease clears. The reproduction numbers R06 and R07 are positive if
k13 + µmr + k7re > kr and
Πlβp
µsl
+ αp + µp > Πp
We can explain R∗06 in terms of the three stages of the malaria life cycle as follows; The
contribution to the reproduction number R06 by each stage is explained below: R0L =(
Πlβl
Q2
)
denes the reproductive ratio for the liver stage. R0B =
(
kSr
µrQ5
)(
n1µil
Q3
)(
ω
ω+µt
)
denes the reproduction ratio for the red blood stage and R0M =
(
Πmcβmc
µgµmc
)
denes the
reproduction ratio for the mosquito stage. The fth root of the reproduction number R06
indicates the path the parasite undergoes through from the mosquito through the liver,
the blood stream before starting another cycle in the mosquito. We can state the following
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stability theorem for the parasite-free equilibrium point.
Theorem 5.2.1 The parasite-free equilibrium is locally asymptotically stable if R06 < 1,
otherwise it is unstable.
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5.2.3 Simulations
The model equations (5.1) to (5.13) require several input parameter values, which can be di-
vided into three sets, namely (i) those that have been measured clinically or experimentally
[TABLE 5.4] and [TABLE 5.5], (ii) those that have been estimated by other researchers
[TABLE 5.4] and [TABLE 5.5], (iii) those that have been estimated by us [TABLE 5.4]
and [TABLE 5.5].
TABLE. 5.4. The table with the parameters, values and source
Parameter Value/range of values Source
Πl 9.9 ∗ 10
5 < Πl < 2 ∗ 10
11
Estimated [15, 19, 68]
βl 4 ∗ 10
(−10)
[19]
µsl 0.004 < µsl < 0.01 Estimated[19]
kl 0.2 Estimated
N 32 [55]
m 10(−8) [5]
µil 0.01 < µil < 0.1 [19]
Πp 0 < Πp < 10
5
Estimated [47, 87]
βp 4 ∗ 10
(−10) < βp < 4 ∗ 10
(−9)
Estimated
αp 0.2 < αp < 0.5 Estimated
k12 0.2 < k12 < 0.3 Estimated
n3 5 < n3 < 30 Estimated
µimc 0.01 < µimc < 0.2 Estimated
µp 0.001 < µp < 0.01 Estimated
kcl 0.02 Estimated
ktp 0.0001 < ktp < 0.25 Estimated
n1 12 < n1 < 32 [55]
µcl 0.01 Estimated
Sr 2.5 ∗ 10
8 < Sr < 2.5 ∗ 10
9
Estimated [89, 101]
k 2 ∗ 10(−9.25) < k < 2 ∗ 10(−8) Estimated [89]
Sensitivity analysis
FIG. 5.1 shows how some parameters are correlated to R07, and how sensitive R07 is to
changes in these parameters. Knowledge of how these parameters aect R07 helps to
determine whether the severity of the disease will be overestimated or underestimated as
these parameters vary. If a parameter is positively correlated to R07 then increasing that
parameter overestimates the severity of the disease. On the other hand, if a parameter
is negatively correlated to R07 then changes in that parameter could underestimate the
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TABLE. 5.5. The table with the parameters, values and source
Parameter Value/range of values Source
µr 0.01 [101]
kb 0.4 Estimated
µri 0.2 [101]
kr 0.001 < kr < 0.01 Estimated
k7 10
(−8)
[5, 89]
k13 0.6 Estimated
µmr 0.0208 < µmr < 0.1 Estimated [89]
γ 0.003 < γ < 0.4 Estimated
ω 10(−4) < ω < 0.01 Estimated
µt 0.01 Estimated
k11 0.02 Estimated
µcr 0.2 Estimated
Πmc 2.4 ∗ 10
2 < Πmc < 2.4 ∗ 10
4
[17]
βmc 10
(−8) < βmc < 10
(−7)
Estimated
µmc 10
(−10) < µmc < 0.025 Estimated
µimc 0.01 < µimc < 0.2 Estimated
µg 0.04 < µg < 0.4 Estimated [89]
ωe 0.04 Estimated
re 2.1 ∗ 10
5
[97, 100]
severity of the disease.
The range of the parameter n1 is known and is given in McQueen and McKenzie [55]. The
parameter µsl is signicantly positively correlated to R07. This is an important parameter
estimated in [19]. Parameters βl and µil are given in [19] and parameter Πmc is given in
[17]. The parameters Πl, Sr, k, which have not been estimated clinically or experimentally
are estimated in [15, 19, 68, 89, 101] respectively. We can see from the sensitivity analysis
that the reproduction number R07 is highly positively correlated to ω, rate of loss or
gain of trophozoites, βmc, infection rate and kr, growth rate due to infection of RBCs.
Parameters k7,N, re, µr, are given/estimated in [5, 55, 89, 97, 100, 101] respectively. The
parameters µg and µmr have not been determined clinically or experimentally but are
estimated in [89]. We can also see that, the reproduction number is negatively correlated
to ktp, µp, µcl, µmc, αp, k13, βp, µt. There is a need to determine these parameters either
clinically or experimentally.
The time used in our simulations is from t = 0 days to 60 days, which, clinically, is the
time for an infected person to show symptoms of malaria. In this example, we have started
treatment on 30th day after the initial infection. This is because, the average time for
clinical symptoms to appear is estimated to be between (8− 25) days although this period
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FIG. 5.1. Diagram shows sensitivity analysis of R07.
can be much longer depending on the immune system of the host [48].
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5.3 Results
The numerical simulation of the model equations (5.1) to (5.13) considers how changes in
the parameters aect the dynamics of the disease and the role of treatment.
5.3.1 Dynamics of the system before treatment
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FIG. 5.2. Diagram shows the parasite-free equilibrium (DFE) at liver stage with R07 =
0.0063.
FIG. 5.2 shows the time plots for the various classes during the liver stage. Susceptible
liver cells (LVCs) drop initially but eventually settle at parasite-free level. All the infected
LVCs, sporozoites and schizonts inside LVCs tend to zero and the disease does not establish
itself.
FIG. 5.3 shows the time plots for the various classes during the blood stage of the disease.
The susceptible RBCs drop initially but eventually settle at parasite-free level which is
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FIG. 5.3. Diagram shows the parasite-free equilibrium (DFE) at blood stage R07 = 0.0063.
high enough to sustain the life. All the infected classes tend to zero. The eector cells
increase logistically.
FIG. 5.4 shows the various classes during the mosquito stage of the replication cycle. The
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FIG. 5.4. Diagram shows the parasite-free equilibrium (DFE) at mosquito stage R07 =
0.0063.
susceptible MGCs drop initially and settle at parasite-free level. All the infected classes
tend to zero.
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FIG. 5.5. Diagram shows the parasite-present equilibrium point (EEP) at liver stage
R07 = 4.7265.
FIG. 5.5, FIG. 5.6 and FIG. 5.7 are time plot of various class during the liver, blood stage
and mosquito stages respectively. It is clear that the disease establishes itself.
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FIG. 5.6. Diagram shows the parasite-present equilibrium point (EEP) at blood stage
R07 = 4.7265.
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FIG. 5.7. Diagram shows the parasite-present equilibrium point (EEP) at mosquito stage
R07 = 4.7265.
FIG. 5.8 shows the variation of ktp and n1 with R06. As ktp increases it reduces the re-
production number R07 in agreement the results of our sensitivity analysis. On the other
hand, increasing µil increases R07 FIG. 5.9.
Increasing killing rate of merozoites by eector cells, reduces the disease manifestation in
the blood as illustrated in the FIG. 5.10. Also increasing the growth rate of merozoites,
increases the severity of the disease manifested by a sharp decline in population of RBCs.
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FIG. 5.8. Shows the contour plot of R07 as a function of an average number of schizonts
release from an infected liver cells that die naturally (n1) and the rate of loss of schizonts
inside liver cells that are killed by eector cells (ktp).
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FIG. 5.9. Shows the contour plot of R07 as a function of the natural death of an infected
liver cells (µil) and natural death of susceptible midgut cells (µmc).
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FIG. 5.10. Shows the contour plot of R07 as a function of the growth rate due to infection
of RBCs (kr) the rate of killing of merozoites by eector cells(k7).
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5.3.2 Treatment strategy
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FIG. 5.11. Diagram shows an application of treatment after 30 days at liver stage and
1 = 0 =⇒ R06 = 4.7265, 1 = 0.3 =⇒ R06 = 4.0980, 1 = 0.7 =⇒ R06 = 2.9200,
1 = 0.99 =⇒ R06 = 0.7491.
FIG. 5.11 shows time plot of various classes during the liver stage as treatment is admin-
istered for drug ecacy ranging from 1 = 0 to 1 = 0.99. The susceptible liver cell popu-
lations do not change due to clearance of the pathogen as the drug ecacy increases. The
infected liver cell populations, Sporozoites and schizonts decrease with increasing ecacy.
The reproduction number is a decreasing function of ecacy, for example, R06 = 4.0980
for 1 = 0 and R06 = 0.7491 for 1 = 0.99.
FIG. 5.12 shows time plot of various classes during the blood stage of the disease in the
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FIG. 5.12. Diagram shows an application of treatment after 30 days at blood stage and
1 = 0 =⇒ R06 = 4.7265, 1 = 0.3 =⇒ R06 = 4.0980, 1 = 0.7 =⇒ R06 = 2.9200,
1 = 0.99 =⇒ R06 = 0.7491.
presence of treatment. The susceptible RBCs population increases with increasing treat-
ment ecacy. The infected classes decrease with increasing treatment ecacy.
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FIG. 5.13. Diagram shows an application of treatment after 30 days at mosquito stage
and 1 = 0 =⇒ R06 = 4.7265, 1 = 0.3 =⇒ R06 = 4.0980, 1 = 0.7 =⇒ R06 = 2.9200,
1 = 0.99 =⇒ R06 = 0.7491.
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5.4 Discussion
We investigated the interaction between the malaria parasites and the immune cells for
all the three stages of malaria life cycle. The model has been studied and results were
presented. The eect of treatment was discussed using numerical results with reasonable
choices of parameter values. Therapy which was represented by drug ecacy 1 and tar-
geted to kill sporozoites, merozoites and gemotocytes.
The model investigated the interaction between the malaria parasites and the immune cells
for all three stages of the malaria life cycle. The three- stage malaria model presents many
challenges in that there are many parameters that are not known clinically. However, us-
ing the known parameters, we have performed a sensitivity analysis ([7]) which has helped
to determine the magnitude and range of our unknown parameters. This analysis has
shown that the reproduction number R07 is positively correlated to the rate of gain/loss
of trophozoites (ω), infection rate (βmc), and growth rate due to infection of RBCs (kr),
and is negatively correlated to rate of loss of schizonts inside the liver cells that are killed
by eector cells (ktp), natural death of sporozoites (µp), natural death of schizonts inside
the liver cells (µcl), natural death of susceptible midgut cells (µmc), rate of gain/loss of
sporozoites (αp), rate of loss of merozoites (k13), infection rate (βp) and natural death of
trophozoites (µt). Overestimation of rate of gain/loss of trophozoites (ω), βmc, and growth
rate due to infection of RBCs (kr) or underestimation of rate of loss of schizonts inside
the liver cells that are killed by eector cells (ktp), µp, µcl, µmc, αp, k13, βp and µt can have
serious implications regarding the prognosis of the disease. There is a need for clinical or
experimental determination of these parameters.
The contour plot results (FIG. 5.8, FIG. 5.9 and FIG. 5.10) have shown how changes in
some parameters aected the reproduction number. The results are in agreement with
the sensitivity and uncertainty analysis results. The graphs corresponding to R07 < 1 and
those corresponding to R07 > 1 are in agreement with the predictions of (Theorem 5.2.1).
As in the previous chapter on treatment, treatment had the eect of slowing down the
depletion of susceptible cells and clearance the parasite populations. Our results showed
that when using therapy with an ecacy of 1 = 0.99, the infected liver cells, and infected
red blood cells take 10 days to revert to a parasite-free equilibrium state R06 = 0.7494.
As in the previous Chapter 4, we recommend a change in the manner treatment is ad-
ministered. Specically, malaria treatment should be administered at health centres like
tuberculosis and in the presence of healthy workers. We believe that only a malaria vaccine
can reliably protect against all stages of malaria infection.
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Conclusion
Mathematical models of interactions of malaria parasites and the host immune system have
been presented in this study. We discussed the mathematical and numerical analysis of
these models. We then introduced treatment ecacy (1) to enable us explore the eect of
treatment on the pathogenesis of malaria. The results obtained from the models presented
in Chapters 4, and 5 are as follows:
1. The model of the blood stage in Chapter 4, revealed that parasite replicative charac-
teristics allow the parasite to evade the immune response during the red blood stage
of malaria infection. We found that, the larger a threshold number of intracellular
parasites released as a results of the natural death of an activated RBC (n1) is, the
longer it takes to produce the parasites and the higher the chance of an infected red
blood cell being identied and apoptosised by the eector cells. Hence we concluded
that in order to minimize the possibility of infected red blood cells being detected
and eliminated by the immune cells, the parasite infects older red blood cells whose
life expectancy is much shorter than the younger cells thereby avoiding the infected
red blood cell from being detected and apoptosised.
2. The eect of drug ecacy at blood stage cycle in Chapter 4 showed that, a high drug
ecacy of 1 = 0.95 could stop the development of the disease. Since most malaria
treatment drugs are of higher ecacy than 0.6, it is possible to combat malaria with
treatment drugs but the administration of drugs should be done at health centres or
hospitals to ensure that patients complete their treatment.
3. The model with three stages of malaria life cycle in Chapter 5, showed that, as the
drug ecacy increases up to 1 = 0.99 and R06 = 0.7494, the populations of the
infected LVC and infected RBC approach the parasite-free equilibrium after 10 days.
Sporozoites, schizonts and gametocytes took more than 10 days to approach the dis-
ease free equilibrium with an ecacy of 1 = 0.99. We found that, treatment had the
86
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eect slowing down the depletion of susceptible cells and clearing the parasite popu-
lations. This showed that an eective drug treatment could stop the development of
disease.
6.1 Limitations and recommendations
Due to the detailed nature of the models developed in this study, some of the parameters
used have not been clinically or experimentally determined before. This has been the
biggest challenge in our assessment. The models studied in this thesis lacked data sets
that would be tted on them so as to validate the predictions of the observed outputs.
We therefore recommend that, the clinicians or experimentalists estimate the unknown
and important parameters such as: rate of loss of schizonts inside the liver cells that are
killed by eector cells (ktp), threshold number as a results of gain due to infection of
susceptible RBC by extracellular parasites (n∗k∗), rate of loss of schizonts due to bursting
of infected RBCs (k11), rate of loss of infected RBCs due to bursting of infected RBCs
(kb), proportion of merozoites (γ), proportion of RBCs (α), growth rate of eector cells
(ωe), natural death of infected midgut cells (µimc), natural death of schizonts inside RBCs
(µcr), growth rate of schizonts (kcl), natural death of sporozoites (µp), natural death of
sporozoites (n3), rate of bursting of infected midgut cells (k12), rate of bursting of infected
liver cells (kl), that have been inuential in the predictions of the models outputs. We
recommend that therapy with highly ecacious drugs would be an eective control measure
in eradicating malaria at all stages but we think that only a malaria vaccine could reliably
protect against all stages malaria infection. We have also shown that chronic infections
can transform manageable malaria into a more active disease. The recommendation from
our study is that; in malaria endemic areas, individuals with malaria or showing malaria
symptoms should be tested for chronic infections and those who test positive for any chronic
infection should be treated for both malaria and the chronic infection. We also recommend
a change in manner treatment is administered. Specically, malaria treatment should be
administered at health centres
6.2 Future work
The models analysed in this work could be extended as follows:
1. Since the model did not incorporate the eect of cytokines (how do cell communicate),
we hope to extend the model by considering the eect of cytokines.
2. Since there is relationship between malaria and HIV/AIDS, we hope to include the
model of co-infection of HIV and Malaria.
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Parameters values and initial variables
used in simulations
In this Appendix we will show some of the parameters used to draw the gures on our
model.
TABLE. A.1. The table that shows the initial variables that used in FIG. (4.3,4.4)
Variables R(0) Rl(0) Ra(0) Pi(0) Pe(0) E(0)
Values(DFE) 5 ∗ 109 0 0 50 0 200
Values(EEP) 5 ∗ 109 0 0 107 0 200
TABLE. A.2. The table with parameters values used in FIG. (4.3)
Parameters Sr µr k α γ µrl kb
Values 2.5 ∗ 10(7.2) 0.01 2 ∗ 10(−9) 0.2 0.0001 0.01 0.4
Parameters µra N k11 n
∗k∗ µpe ω Spe
Values 0.014 32 0.01 10(−8) 0.0208 0.04 20
Parameters kpi n1 m ktp re
Values 0.08745 24 10(−8) 0.0009 2000
88
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TABLE. A.3. The table with parameters values used in FIG. (4.4)
Parameters Sr µr k α γ µrl kb
Values 2.5 ∗ 10(7.2) 0.01 2 ∗ 10(−9.46) 0.2 0.001 0.008 0.4
Parameters µra N k11 n
∗k∗ µpe ω Spe
Values 0.014 32 0.01 10(−8) 0.0208 0.04 15
Parameters kpi n1 m ktp re
Values 0.08745 12 10(−8) 0.0009 800
TABLE. A.4. The table that shows the initial variables that used in FIG. (4.5,4.6)
Variables R(0) Rl(0) Ra(0) Pi(0) Pe(0) E(0)
Values(DFE) 1011 0 0 10(10) 0 200
TABLE. A.5. The table with parameters values used in FIG. (4.5,4.6)
Parameters Sr µr k α γ µrl kb
Values 2 ∗ 10(9) 0.01 2 ∗ 10(−9) 0.1 0.04 0.01 0.4
Parameters µra N k11 n
∗k∗ µpe ω Spe
Values 0.014 32 0.01 10(−8) 0.0208 0.04 10
Parameters kpi m ktp re
Values 0.08745 10(−8) 0.01 4000
TABLE. A.6. The table that shows the initial variables that used in FIG. (4.7)
Variables R(0) Rl(0) Ra(0) Pi(0) Pe(0) E(0)
Values(DFE) 5 ∗ 109 0 0 5 ∗ 10(7) 0 200 1 1 1
TABLE. A.7. The table with parameters values used in FIG. (4.7)
Parameters Sr µr k α γ µrl kb
Values 2.5 ∗ 10(7.2) 0.01 2 ∗ 10(−9.46) 0.2 0.0001 0.008 0.4
Parameters µra N k11 n
∗k∗ µpe ω Spe
Values 0.014 32 0.01 10(−8) 0.0208 0.04 20
Parameters kpi m ktp re n1
Values 0.08745 10(−8) 0.008745 880 12
TABLE. A.8. The table that shows the initial variables that used in FIG. (4.8,4.9, 4.10)
Variables R(0) Rl(0) Ra(0) Pi(0) Pe(0) E(0)
Values(4.8) 5 ∗ 109 0 0 5 ∗ 10(7) 0 200
Values(4.9) 5 ∗ 109 0 0 5 ∗ 10(8) 10 200
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TABLE. A.9. The table with parameters values used in FIG. (4.8,4.9,4.10)
Parameters Sr µr k α γ µrl kb
Values 2.5 ∗ 10(7.2) 0.01 2 ∗ 10(−9.46) 0.2 0.008 0.008 0.4
Parameters µra N k11 n
∗k∗ µpe ω Spe
Values 0.014 32 0.01 10(−8) 0.0208 0.04 20
Parameters kpi m ktp re n1
Values 0.08745 10(−8) 0.008745 880 12
TABLE. A.10. The table that shows the initial variables that used in FIG.(4.11,4.12,
4.13,4.14)
Variables R(0) Rl(0) Ra(0) Pi(0) Pe(0) E(0)
Values 5 ∗ 109 0 0 50 0 200
TABLE. A.11. The table with parameters values used in FIG. (4.11,4.12, 4.13,4.14)
Parameters Sr µr k α γ µrl kb
Values 2.5 ∗ 10(7.2) 0.01 2 ∗ 10(−9) 0.2 0.0001 0.01 0.4
Parameters µra N k11 n
∗k∗ µpe ω Spe
Values 0.014 32 0.01 10(−8) 0.0208 0.04 20
Parameters kpi m ktp re n1
Values 0.08745 10(−8) 0.008745 2000 24
TABLE. A.12. The table that shows the initial values used in FIG. (4.15,4.16)
Variables R(0) Rl(0) Ra(0) Pi(0) Pe(0) E(0)
Values 5 ∗ 109 0 0 107 0 200
TABLE. A.13. The table with parameters and values used in FIG. (4.15,4.16)
Parameters Sr µr k α γ µrl kb
Values 2.5 ∗ 10(7.3) 0.01 2 ∗ 10(−9.25) 0.1 0.001 0.008 0.5
Parameters µra N k11 n
∗k∗ µpe ω Spe
Values 0.014 32 0.02 10(−8) 0.0208 0.05 20
Parameters kpi n1 m ktp re
Values 0.08745 12 10(−8) 0.0009 880
TABLE. A.14. The table that shows the initial values used in FIG. (5.2,5.3,5.4)
Variables Sl(0) Il(0) P (0) Cl(0) R(0) Ri(0) Mr
Values 1011 0 0 1 5 ∗ 109 0 1
Variables T (0) Cr(0) Smc(0) Imc(0) G(0) E(0)
Values 1 1 106 0 1 200
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TABLE. A.15. The table with parameters and values used in FIG. (5.2,5.3,5.4)
Parameters piil βl µsl kl N m µil
Values 3 ∗ 10(7.5) 4 ∗ 10(−10) 0.004 0.2 32 10(−8) 0.01
Parameters αp k12 n3 µimc µp kcl ktp
Values 0.2 0.2 30 0.01 0.01 0.02 0.25
Parameters Sr k µr kb µri µil kr
Values 2.5 ∗ 10(7.2) 2 ∗ 10(−9.25) 0.01 0.4 0.2 0.01 0.001
Parameters γ ω µt k11 µcr pimc βmc
Values 0.4 10(−4) 0.01 0.02 0.2 2.4 ∗ 104 10(−7)
Parameters µg ωe re βp n1 µmr k13
Values 0.4 0.04 2.1 ∗ 105 4 ∗ 10(−10) 24 0.0208 0.6
Parameters µcl k7 µmc pip
Values 0.01 10(−8) 0.025 0.08
TABLE. A.16. The table that shows the initial values used in FIG. (5.5,5.6,5.7)
Variables Sl(0) Il(0) P (0) Cl(0) R(0) Ri(0) Mr
Values 1010.5 0 0 1 5 ∗ 109 0 1
Variables T (0) Cr(0) Smc(0) Imc(0) G(0) E(0)
Values 1 1 105 0 1 200
TABLE. A.17. The table with parameters and values used in FIG.(5.8,5.9, 5.10,5.5,5.6,5.7,
5.11,5.12, 5.13)
Parameters piil βl µsl kl N m µil
Values 3 ∗ 10(7.7) 4 ∗ 10(−10) 0.01 0.2 32 10(−8) 0.01
Parameters αp k12 n3 µimc µp kcl ktp
Values 0.5 0.3 5 0.2 0.001 0.02 0.0001
Parameters Sr k µr kb µri µil kr
Values 2.5 ∗ 10(7.3) 2 ∗ 10(−8) 0.01 0.4 0.2 0.01 0.01
Parameters γ ω µt k11 µcr pimc βmc
Values 0.4 10(−4) 0.01 0.02 0.2 2.4 ∗ 104 10(−7)
Parameters µg ωe re βp n1 µmr k13
Values 0.4 0.04 2.1 ∗ 105 4 ∗ 10(−9) 12 0.01 0.6
Parameters µcl k7 µmc pip
Values 0.01 10(−8) 10(−10) 0.08
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